Village Farms International (VFF) 10-K 9 Mar 23 2021 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 08, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2022
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Trading Symbol	VFF
Entity Registrant Name	VILLAGE FARMS INTERNATIONAL, INC.
Entity Central Index Key	0001584549
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Interactive Data Current	Yes
Entity Well-known Seasoned Issuer	No
Entity Filer Category	Accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Security Exchange Name	NASDAQ
Entity Address, Country	CA
Title of 12(b) Security	Common Shares, without par value
Entity File Number	001-38783
Entity Incorporation State Country Code	A6
Entity Tax Identification Number	98-1007671
Entity Address, State or Province	BC
Entity Address, Address Line One	4700-80th Street
Entity Address, City or Town	Delta
Entity Address, Postal Zip Code	V4K 3N3
City Area Code	604
Local Phone Number	940-6012
Document Annual Report	true
Document Transition Report	false
ICFR Auditor Attestation Flag	true
Entity Common Stock, Shares Outstanding		110,238,929
Entity Public Float			$ 200,095,838
Auditor Name	PricewaterhouseCoopers LLP
Auditor Firm ID	271
Auditor Location	Vancouver, British Columbia, Canada

Consolidated Statements of Fina

Consolidated Statements of Financial Position - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 16,676	$ 53,417
Restricted cash	5,000	5,250
Trade receivables	27,558	34,360
Inventories	70,582	68,677
Other receivables	309	616
Income tax receivable	6,900	2,430
Prepaid expenses and deposits	5,959	10,209
Total current assets	132,984	174,959
Non-current assets
Property, plant and equipment	207,701	215,704
Investments	2,109	2,109
Note receivable - joint venture		3,256
Goodwill	66,225	117,533
Intangibles	37,157	26,394
Deferred tax asset	4,201	16,766
Right-of-use assets	9,132	7,609
Other assets	5,776	2,581
Total assets	465,285	566,911
Current liabilities
Line of credit	7,529	7,760
Trade payables	24,894	22,597
Current maturities of long-term debt	9,646	11,416
Accrued sales taxes	11,594	3,899
Accrued loyalty program	2,060	2,098
Accrued liabilities	13,064	14,168
Lease liabilities - current	1,970	962
Other current liabilities	1,458	1,413
Total current liabilities	72,215	64,313
Non-current liabilities
Long-term debt	43,821	50,419
Deferred tax liability	19,756	18,657
Lease liabilities - non-current	7,785	6,711
Other liabilities	1,714	1,973
Total liabilities	145,291	142,073
Commitments and contingencies (note 14)
MEZZANINE EQUITY
Redeemable non-controlling interests	16,164	16,433
SHAREHOLDERS’ EQUITY
Common stock, no par value per share - unlimited shares authorized; 91,788,929 shares issued and outstanding at December 31, 2022 and 88,233,929 shares issued and outstanding at December 31, 2021.	372,429	365,561
Additional paid in capital	13,372	9,369
Accumulated other comprehensive (loss) income	(8,371)	6,696
Retained earnings	(74,367)	26,779
Total Village Farms International, Inc. shareholders' equity	303,063	408,405
Non-controlling interest	767
Total shareholders' equity	303,830	408,405
Total liabilities, mezzanine equity and shareholders’ equity	$ 465,285	$ 566,911

Consolidated Statements of Fi_2

Consolidated Statements of Financial Position (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Assets [Abstract]
Allowance for doubtful accounts receivable	$ 0	$ 39
Common stock, no par value	$ 0	$ 0
Common Stock, Shares, Issued	91,788,929	88,233,929
Common Stock, Shares, Outstanding	91,788,929	88,233,929

Consolidated Statements of Inco

Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Sales	$ 293,572	$ 268,020	$ 170,086
Cost of sales	(266,075)	(222,841)	(159,126)
Gross margin	27,497	45,179	10,960
Selling, general and administrative expenses	(68,278)	(46,384)	(19,086)
Share-based compensation	(3,987)	(7,533)	(6,142)
Interest expense	(3,244)	(2,835)	(2,056)
Interest income	207	126	625
Foreign exchange loss	(2,255)	(476)	(136)
Gain on settlement agreement			4,681
Gain on acquisition			23,631
Other (expense) income	(115)	(420)	(873)
Write-off of note receivable	(592)		(3,791)
Impairments	(43,299)
(Loss) income before taxes and (loss) income from equity method investments	(94,066)	(12,343)	7,813
(Provision for) recovery of income taxes	(4,681)	3,526	2,790
(Loss) income from equity method investments	(2,668)	(308)	1,005
(Loss) income including non-controlling interests	(101,415)	(9,125)	11,608
Less: net loss attributable to non-controlling interests, net of tax	269	46
Net (loss) income attributable to Village Farms International, Inc.	$ (101,146)	$ (9,079)	$ 11,608
Basic (loss) income per share attributable to Village Farms International, Inc. shareholders	$ (1.13)	$ (0.11)	$ 0.20
Diluted (loss) income per share attributable to Village Farms International, Inc. shareholders	$ (1.13)	$ (0.11)	$ 0.19
Weighted average number of common shares used in the computation of net (loss) income per share (in thousands):
Basic	89,127	82,161	58,526
Diluted	89,127	82,161	61,490
Other comprehensive (loss) income:
Foreign currency translation adjustment	$ (15,460)	$ 441	$ 6,730
Comprehensive (loss) income attributable to Village Farms International, Inc. shareholders	$ (116,606)	$ (8,638)	$ 18,338

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity and Mezzanine Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2019	$ 126,459	$ 98,333	$ 4,351	$ (475)	$ 24,250
Beginning Balance (in shares) at Dec. 31, 2019		52,657
Net proceeds from issuance of common stock / Shares issued in public offering, net of issuance costs	42,550	$ 42,550
Net proceeds from issuance of common stock / Shares issued in pubic offering, net of issuance costs (in shares)		12,990
Warrants issued in public offering	11,369		11,369
Shares issued on exercise of stock options (in shares)		1,265
Shares issued on exercise of stock options	425	$ 692	(267)
Share-based compensation	6,142	4,093	2,049
Cumulative translation adjustment	6,730			6,730
Net income (loss)	11,608				11,608
Ending Balance at Dec. 31, 2020	205,283	$ 145,668	17,502	6,255	35,858
Ending Balance (in shares) at Dec. 31, 2020		66,912
Net proceeds from issuance of common stock / Shares issued in public offering, net of issuance costs	127,489	$ 127,489
Net proceeds from issuance of common stock / Shares issued in pubic offering, net of issuance costs (in shares)		10,887
Shares issued in acquisition	63,044	$ 63,044
Shares issued in acquisition (in shares)		7,118
Shares issued on exercise of warrants (in shares)		3,188
Shares issued on exercise of warrants	18,495	$ 29,050	(10,555)
Shares issued on exercise of stock options (in shares)		177
Shares issued on exercise of stock options	199	$ 310	(111)
Share re-purchases	(5,000)		(5,000)
Share re-purchases (in shares)		(535)
Share-based compensation	7,533		7,533
Share-based compensation (in shares)		487
Mezzanine Equity, Recognition of non-controlling interest on acquisition	16,479
Cumulative translation adjustment	441			441
Mezzanine Equity, Net loss	(46)
Net income (loss)	(9,079)				(9,079)
Mezzanine Equity, Ending balance at Dec. 31, 2021	16,433
Ending Balance at Dec. 31, 2021	408,405	$ 365,561	9,369	6,696	26,779
Ending Balance (in shares) at Dec. 31, 2021		88,234
Net proceeds from issuance of common stock / Shares issued in public offering, net of issuance costs	7,085	$ 6,692		393
Net proceeds from issuance of common stock / Shares issued in pubic offering, net of issuance costs (in shares)		3,175
Shares issued on exercise of stock options (in shares)		180
Shares issued on exercise of stock options	192	$ 176	16
Share-based compensation	3,987		3,987
Share-based compensation (in shares)		200
Recognition of non-controlling interest on acquisition	767					$ 767
Cumulative translation adjustment	(15,460)			(15,460)
Mezzanine Equity, Net loss	(269)
Net income (loss)	(101,146)				(101,146)
Mezzanine Equity, Ending balance at Dec. 31, 2022	16,164
Ending Balance at Dec. 31, 2022	$ 303,830	$ 372,429	$ 13,372	$ (8,371)	$ (74,367)	$ 767
Ending Balance (in shares) at Dec. 31, 2022		91,789

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows (used in) provided by operating activities:
Net (loss) income attributable to Village Farms International, Inc. shareholders	$ (101,146)	$ (9,079)	$ 11,608
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	13,054	12,709	6,825
Amortization of deferred charges	214	300	115
Share of loss (income) from joint venture	2,668	308	(1,005)
Net loss attributable to non-controlling interest	(269)	(46)
Interest expense	3,244	2,835	2,056
Interest income	(207)	(126)	(625)
Interest paid on long-term debt	(3,420)	(3,306)	(1,295)
Unrealized foreign exchange loss	(83)
Impairments	43,299
Inventory impairment	11,038
Write-off of note receivable	592		3,791
Gain on settlement agreement			(4,681)
Loss on disposal of assets	(7)	259	922
Gain on acquisition of Pure Sunfarms			(23,631)
Non-cash lease expense	(604)	(1,351)	(1,150)
Other		366
Interest paid on finance lease			(4)
Share-based compensation	3,987	7,533	6,142
Deferred income taxes	9,831	(2,866)	(6,462)
Changes in non-cash working capital items	(2,246)	(47,149)	13,072
Net cash (used in) provided by operating activities	(19,889)	(39,567)	5,678
Cash flows used in investing activities:
Purchases of property, plant and equipment	(14,292)	(21,656)	(3,419)
Purchases of intangibles			(92)
Advances to joint ventures		(20)	(177)
Acquisitions, net	(5,873)	(40,685)	(34,603)
Investment in minority interests		(1,109)	(1,226)
Investment in joint ventures			(11,713)
Notes receivable	(734)
Net cash used in investing activities	(20,899)	(63,470)	(51,230)
Cash flows provided by financing activities:
Proceeds from borrowings	7,321	19,669	10,619
Repayments on borrowings	(9,709)	(9,454)	(6,292)
Proceeds from issuance of common stock and warrants	6,692	135,000	57,212
Issuance costs		(7,511)	(3,293)
Proceeds from exercise of stock options	192	199	425
Proceeds from exercise of warrants		18,495
Share re-purchases		(5,000)
Payments on capital lease obligations	0	(17)	(63)
Payment of note payable related to acquisition		(15,498)
Net cash provided by financing activities	4,496	135,883	58,608
Effect of exchange rate changes on cash and cash equivalents	(699)	142	634
Net (decrease) increase in cash, cash equivalents and restricted cash	(36,991)	32,988	13,690
Cash, cash equivalents and restricted cash, beginning of period	58,667	25,679	11,989
Cash, cash equivalents and restricted cash, end of period	$ 21,676	58,667	25,679
Supplemental disclosure of non-cash activities:
Shares issued for acquisitions		63,044
Supplemental cash flow information:
Income taxes paid		$ 1,801	$ 158

Description Of Business

Description Of Business	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description Of Business	1. DESCRIPTION OF BUSINESS Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”, “we”, “us”, or “our”) is a corporation existing under the Ontario Business Corporations Act. VFF’s principal operating subsidiaries as of December 31, 2022 are Village Farms Canada Limited Partnership, Village Farms, L.P., Pure Sunfarms Corp. (“Pure Sunfarms”), and Balanced Health Botanicals, LLC (“Balanced Health”). VFF also owns a 70 % interest in Rose LifeScience Inc. (“Rose”) and an 85 % interest in Leli Holland B.V. ("Leli"). The address of the registered office of VFF is 4700-80th Street, Delta, British Columbia, Canada, V4K 3N3. The Company’s shares are listed on Nasdaq Capital Market (“Nasdaq”) under the symbol “VFF”. Village Farms owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers and cucumbers. It’s wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company’s wholly owned subsidiary, Balanced Health, develops and sells high-quality, cannabidiol (“CBD”) based products including ingestible, edible and topical applications. Through its 70 % ownership of Rose, the Company has a substantial presence in the Province of Quebec as a cannabis supplier, producer and commercialization expert.

Basis of Presentation

Basis of Presentation	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	2. BASIS OF PRESENTATIO N The Consolidated Financial Statements reflect the accounts of the Company and our majority-owned and controlled subsidiaries. All intercompany accounts and transactions between our consolidated operations have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the amounts of assets and liabilities and the disclosures regarding contingent assets and liabilities at period end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material.

Summary Of Significant Accounti

Summary Of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Summary Of Significant Accounting Policies	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revenue Recognition The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods at a fixed price. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders received from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and their performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. Revenue from the sale of cannabis inventories in the course of ordinary activities is measured at the fair value of the consideration received or receivable, net of returns, trade discounts, volume rebates and excise duty. The Company recognizes revenue when it has fulfilled the performance obligation to the customer through the delivery and transfer of control of the promised goods. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is still in the Company’s physical possession, and title and risk of loss has passed to the customer. Revenue is recognized when all specific requirements for transfer of control under a bill-and-hold arrangement have been met. The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption. The Company has elected to exclude taxes collected from its customers assessed by government authorities that are both imposed on and concurrent with a specific revenue-producing transaction from our determination of transaction price. Direct-to-consumer product sales for loyalty members contain two distinct performance obligations for which the Company allocates the transaction price based on the relative stand-alone value of each performance obligation, such that both revenue related to the delivery of the underlying purchased goods and deferred revenue for loyalty points issued to the customer are recognized based on the allocated consideration of value, after giving consideration to loyalty point breakage. The loyalty liability represents a performance obligation to provide goods for free or at a discount to loyalty members in exchange for the redemptions of points earned from past activities. Judgment is required in determining whether the Company is the principal or agent in certain transactions. We evaluate the presentation of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e. “gross”), or we arrange for other parties to provide the service to the end-user and are an agent (i.e. “net”). Revenue received from shipping and handling fees is reflected in net sales. Shipping and handling costs are included in cost of sales as incurred or at the time revenue is recognized for the related goods, whichever comes first. Redeemable Non-Controlling Interest Non-controlling interest (“NCI”) in subsidiaries that are redeemable for cash or other assets outside of our control are classified as temporary mezzanine equity, outside of equity and liabilities. Initial measurement is at acquisition date fair value and subsequent measurement is at the greater of the carrying value or the redemption value. C hanges in the redemption value are recognized immediately as they occur and the carrying amount of the redeemable NCI is adjusted to equal the redemption value at the end of each reporting period. This method views the end of the reporting period as if it were also the redemption date for the instrument. I ncreases or decreases in the estimated redemption amount are recorded with corresponding adjustments against equity and are reflected in the computation of earnings per share. However, the amount presented in temporary equity should be no less than the initial amount reported in temporary equity for the instrument. Foreign Currency Translation Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency at the exchange rates in effect at the reporting date. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated to the functional currency at the exchange rate in effect when the fair value was determined. Foreign currency differences are generally recognized in net income. Non-monetary items that are measured based on historical cost in a foreign currency are translated to the functional currency using the exchange rate in effect at the date of the transaction giving rise to the item. Income Taxes The Company uses the asset and liability method of accounting for income taxes. Temporary differences arising between the tax basis of an asset or liability and its carrying amount on the Consolidated Statement of Financial Position are used to calculate future income tax assets and liabilities. This method also requires the recognition of deferred tax benefits, such as net operating loss carryforwards. Valuation allowances are recorded as appropriate to reduce deferred tax assets to the amount considered likely to be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income (losses) in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment of the change. A tax benefit from an uncertain tax position is recognized only if we believe it is more likely than not that the position will be sustained on its technical merits. If the recognition threshold for the tax position is met, only the portion of the tax benefit that we believe is greater than 50 percent likely to be realized is recorded. Cash and Cash Equivalents Cash and cash equivalents consist of cash deposits held with banks, and other highly liquid short-term interest-bearing securities with maturities at the date of purchase of three months or less. Restricted Cash Restricted cash, as of December 31, 2022 and 2021 includes a cash deposit required by the Company’s directors’ and officers’ insurance policy which is managed by an insurer and held as a cell captive within a Bahamas-based financial institution. T rade Receivables Trade receivables, net of the allowance for doubtful accounts, represent their estimated net realizable value, which approximates fair value. Provisions for doubtful accounts are recorded based on historical collection experience and the age of the receivables. Receivables are written off when they are deemed uncollectible. Inventories Inventories are valued at the lower of cost or net realizable value. The cost of inventory includes capitalized production costs, including labor, materials, post-harvest costs and depreciation. Inventoriable costs are expensed to cost of goods sold on the Consolidated Statement of (Loss) Income in the same period as finished products are sold. The amount of any write-down of inventories to net realizable value and all losses of inventories are recognized as an expense in the period when the write-down or loss occurs. Intangible Assets The Company’s intangible assets are purchased and acquired through business combinations and have both finite and infinite useful lives. They are measured at cost less accumulated amortization and any accumulated impairment losses. Amortization is calculated based on the cost of the intangible assets less their estimated residual values using the straight-line method over their estimated useful lives and is generally recognized in profit or loss. Amortization methods, useful lives and residual values are reviewed at each reporting date and adjusted when necessary. Classification Estimated Useful Lives Licenses 5 - 22 years Brand and trademarks Indefinite Customer relationships 10 years Computer software 3 - 5 years Business Combinations The Company recognizes and measures the assets acquired and liabilities assumed, including contingent assets and liabilities, at their respective fair values on the date of acquisition. Any excess of the purchase consideration over the net fair value of tangible and identified intangible assets acquired less liabilities assumed is recorded as goodwill. The costs of business acquisitions, including fees for accounting, legal, professional consulting and valuation specialists, are expensed as incurred. Purchase price allocations may be preliminary and, during the measurement period not to exceed one year from the date of acquisition, changes in assumptions and estimates that result in adjustments to the fair value of assets acquired and liabilities assumed are recorded in the period the adjustments are determined. For business combinations achieved in stages, the Company’s previously held interest in the acquiree is remeasured at its acquisition date fair value, with the resulting gain or loss recorded in the Statements of (Loss) Income. For a pre-existing relationship between the Company and the acquiree, that is not extinguished on the business combination, such a relationship is considered effectively settled as part of the business combination even if it is not legally cancelled. At the acquisition date, it becomes an intercompany relationship and is eliminated upon consolidation. Goodwill Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired in a business acquisition. Goodwill is allocated to reporting units and tested for impairment annually as of December 31 each year and when events or changes in circumstances indicate that the carrying value of a reporting unit exceeds its fair value. The Company generally elects to utilize the optional qualitative assessment for goodwill to determine whether it is more likely than not that the carrying value of a reporting unit is higher than its fair value. If it is determined that the fair value is more likely than not to be lower than the carrying value, a quantitative goodwill impairment test is performed by determining the fair value of the reporting unit. The fair value of a reporting unit is determined using either the income approach utilizing estimates of discounted future cash flows or the market approach utilizing recent transaction activity for comparable properties. These approaches are considered level 3 fair value measurements. If the carrying amount of the reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit. Property, Plant and Equipment Property, plant and equipment is initially recorded at cost. Depreciation of plant and equipment is determined on the straight-line method over the following useful lives of the assets: Classification Estimated Useful Lives Leasehold and land improvements 5 - 20 years Buildings 4 - 30 years Machinery and equipment 3 - 30 years Impairments of Long-Lived Assets Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Long-lived assets are grouped with other assets to the lowest level to which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Management assesses the recoverability of the carrying cost of the assets based on a review of projected undiscounted cash flows. If an asset is held for sale, management reviews its estimated fair value less cost to sell. Fair value is determined using pertinent market information, including appraisals or broker’s estimates, and/or projected discounted cash flows. In the event an impairment loss is identified, it is recognized based on the amount by which the carrying value exceeds the estimated fair value of the long-lived asset. Segment Reporting Operating segments are reported in a manner consistent with internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (“CEO”). The Company has identified four operating segments – Produce, Cannabis-Canada, Cannabis-U.S. and Energy. Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs based on quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets and liabilities in active markets, or quoted prices for identical assets and liabilities in markets that are not active. Level 3: Unobservable inputs that reflect our own assumptions. Share-Based Compensation The Company grants stock options and performance-based restricted stock (“RS”) to certain employees and directors. Compensation costs for awards of stock-based compensation settled in shares are determined based on the fair value of the share-based instrument at the time of grant and are recognized as expense over the vesting period of the share-based instrument. The Company recognizes forfeitures as they occur. Stock options generally vest over three years ( 33 % per year following the grant date) and expire after ten years . Each tranche in an award is considered a separate award with its own vesting period. The fair value of each tranche is measured at the date of grant using the Black-Scholes option pricing model. Compensation expense is recognized over the tranche’s vesting period by increasing additional paid-in capital based on the number of awards expected to vest. The number of awards expected to vest is reviewed at least annually, with any impact recognized immediately. RS grants will be settled using the Company’s own equity and issued from treasury if the performance standard is met. The equity-settled share-based compensation is measured at the fair value of the Company’s Common Shares as at the grant date in accordance with the terms of the Company’s Stock Compensation Plan. The fair value determined at the grant date is charged to income when performance-based vesting conditions are met, based on the number of RS that will eventually be converted to Common Shares, with a corresponding increase in equity. Advertising Advertising costs are presented within selling, general and administrative costs in the Consolidated Statements of Operations. The Company supports its products with advertising to build brand awareness of the Company’s various products in addition to other marketing programs executed by the Company’s marketing teams. Advertising costs for the years ended December 31, 2022 and 2021 were $ 6,122 and $ 3,473 , respectively. New Accounting Pronouncements In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) . ASU 2020-04 provides optional expedients and exceptions for applying GAAP to debt instruments, derivatives, and other contracts that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform. This guidance is optional and may be elected through December 31, 2022 using a prospective application on all eligible contract modifications. The Company has a line of credit that incorporates LIBOR as a referenced interest rate. It is difficult to predict what effect, if any, the phase-out of LIBOR and the use of alternative benchmarks may have on the Company’s business or on the overall financial markets. The Company has not adopted any of the optional expedients or exceptions through December 31, 2022 but will continue to evaluate the possible adoption of any such expedients or exceptions.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventories	4. IN VENTORIES Inventories consisted of the following: Classification December 31, 2022 December 31, 2021 Cannabis: Raw materials $ 1,089 $ 2,071 Work-in-process 10,872 5,056 Finished goods 36,094 32,161 Packaging 6,909 5,877 Produce and Energy: Crop inventory 14,886 19,475 Purchased produce inventory 599 2,485 Spare parts inventory and packaging 133 1,552 Inventory $ 70,582 $ 68,677 During the fourth quarter of 2022 , the Company recognized $ 11,038 of inventory impairments relative to its net realizable value. There were no inventory impairments recognized for the years ended December 31, 2021 and 2020.

Property Plant And Equipment

Property Plant And Equipment	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Property Plant And Equipment	5. PRO PERTY, PLANT AND EQUIPMENT Property, plant and equipment consisted of the following: Classification December 31, 2022 December 31, 2021 Land $ 13,411 $ 14,095 Leasehold and land improvements 5,372 5,224 Buildings 214,146 184,444 Machinery and equipment 82,396 79,070 Construction in progress 10,033 39,206 Less: Accumulated depreciation ( 117,657 ) ( 106,335 ) Property, plant and equipment, net $ 207,701 $ 215,704 Depreciation expense on property, plant and equipment, was $ 10,795 , $ 12,709 and $ 6,825 for the years ending December 31, 2022, 2021 and 2020 , respectively.

Pure Sunfarms Acquisitions

Pure Sunfarms Acquisitions	12 Months Ended
	Dec. 31, 2022
Business Combinations [Abstract]
Acquisitions	6. PURE SUNFARMS ACQUISITION O n November 2, 2020 , Village Farms consummated a definitive purchase and sale agreement with Emerald Health Therapeutics Inc. (“Emerald”) , acquiring 36,958,500 Common Shares in the capital of Pure Sunfarms owned by Emerald, and increasing Village Farms’ ownership of Pure Sunfarms to 100 %. The shares were acquired for a total purchase price of C$ 79.9 million (US$ 60.0 million), satisfied through an initial C$ 60.0 million (US$ 45.0 million) cash payment and a C$ 19.9 million (US$ 15.0 million) secured promissory note payable to Emerald, which was repaid in full on February 8, 2021. The acquisition was deemed a business combination and the purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. The Company used information available to make fair value determinations and engaged independent valuation specialists to assist in the fair value determination of acquired intangible assets. The estimated fair value of licenses was determined using a multi-period excess earnings method. This earnings-based method considers the net present value of the licenses’ cash flows discounted at an asset specific discount rate. The net present value attributable to the licenses deducts the contributory asset charges used in connection with the licenses. The estimated fair value of the brand was determined using the relief-from-royalty method. This method assumes that the brand has value to the extent that their owner is relieved of the obligation to pay royalties for the benefits received from them. This method requires the Company to estimate the future revenues for the related brand, the appropriate royalty rate, and an asset specific discount rate. This measure of fair value requires significant judgment about the value a market participant would be willing to pay to achieve the benefits associated with the brand. Acquired property, plant and equipment and software were valued using the replacement cost method, which requires the Company to estimate the costs to construct an asset of equivalent utility at prices available at the time of the valuation analysis, with adjustments in value for physical deterioration and functional and economic obsolescence. Upon the acquisition of Pure Sunfarms, the Company identified goodwill of C$ 30,618 (US$ 22,596 ). This goodwill was calculated as the difference between the fair value of the consideration issued for the acquisition of Pure Sunfarms and the fair value of all assets and liabilities acquired. The goodwill is attributable to the acquired workforce and potential for growth through the conversion of the Delta 1 greenhouse facility and future accretive acquisitions. The Company is required to record a deferred tax liability for the difference between the assigned values and the tax bases of assets acquired and liabilities assumed. None of the goodwill is deductible for tax purposes. As a result of the acquisition, the Company also recognized a gain of $ 23.6 million due to the revaluation of its previously held investment in Pure Sunfarms to its fair value at the acquisition date. The accounting for the business combination was considered complete for the year ended December 31, 2020. The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables $ 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180 The change in goodwill between November 2, 2020 and December 31, 2022 is due to the effect of foreign currency translation. Prior to its acquisition on November 2, 2020, the Company accounted for its investment in Pure Sunfarms, using the equity method. The Company determined that Pure Sunfarms was a variable interest entity (“VIE”), however the Company did not consolidate Pure Sunfarms because the Company was not the primary beneficiary. Although the Company was able to exercise significant influence over the operating and financial policies of Pure Sunfarms through its then 58.7 % majority interest, the Company shared joint control of the board of directors and therefore was not the primary beneficiary. For the three and nine months ended September 30, 2020, the Company’s equity earnings from Pure Sunfarms were $ 1,443 and $ 5,437 , respectively. On March 2, 2020, pursuant to the Settlement Agreement, Emerald transferred to the Company 2.5 % of additional equity in Pure Sunfarms. The Company determined the fair value of the equity received from Emerald to be C$ 6.5 million (US$ 4.7 million). The Company recorded this amount as a gain and included it as a gain on settlement agreement on the Consolidated Statement of Income (Loss) and Comprehensive Income (Loss) for the year ended December 31, 2020. For the period January 1, 2020 to November 1, 2020, the Company's share of the joint venture consisted of the following: Balance, January 1, 2020 $ 41,334 Investments in joint venture 16,393 Share of net income for the year 4,980 Balance, November 1, 2020 $ 62,707

BHB Acquisition

BHB Acquisition	12 Months Ended
	Dec. 31, 2022
Business Acquisition [Line Items]
Acquisitions	6. PURE SUNFARMS ACQUISITION O n November 2, 2020 , Village Farms consummated a definitive purchase and sale agreement with Emerald Health Therapeutics Inc. (“Emerald”) , acquiring 36,958,500 Common Shares in the capital of Pure Sunfarms owned by Emerald, and increasing Village Farms’ ownership of Pure Sunfarms to 100 %. The shares were acquired for a total purchase price of C$ 79.9 million (US$ 60.0 million), satisfied through an initial C$ 60.0 million (US$ 45.0 million) cash payment and a C$ 19.9 million (US$ 15.0 million) secured promissory note payable to Emerald, which was repaid in full on February 8, 2021. The acquisition was deemed a business combination and the purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. The Company used information available to make fair value determinations and engaged independent valuation specialists to assist in the fair value determination of acquired intangible assets. The estimated fair value of licenses was determined using a multi-period excess earnings method. This earnings-based method considers the net present value of the licenses’ cash flows discounted at an asset specific discount rate. The net present value attributable to the licenses deducts the contributory asset charges used in connection with the licenses. The estimated fair value of the brand was determined using the relief-from-royalty method. This method assumes that the brand has value to the extent that their owner is relieved of the obligation to pay royalties for the benefits received from them. This method requires the Company to estimate the future revenues for the related brand, the appropriate royalty rate, and an asset specific discount rate. This measure of fair value requires significant judgment about the value a market participant would be willing to pay to achieve the benefits associated with the brand. Acquired property, plant and equipment and software were valued using the replacement cost method, which requires the Company to estimate the costs to construct an asset of equivalent utility at prices available at the time of the valuation analysis, with adjustments in value for physical deterioration and functional and economic obsolescence. Upon the acquisition of Pure Sunfarms, the Company identified goodwill of C$ 30,618 (US$ 22,596 ). This goodwill was calculated as the difference between the fair value of the consideration issued for the acquisition of Pure Sunfarms and the fair value of all assets and liabilities acquired. The goodwill is attributable to the acquired workforce and potential for growth through the conversion of the Delta 1 greenhouse facility and future accretive acquisitions. The Company is required to record a deferred tax liability for the difference between the assigned values and the tax bases of assets acquired and liabilities assumed. None of the goodwill is deductible for tax purposes. As a result of the acquisition, the Company also recognized a gain of $ 23.6 million due to the revaluation of its previously held investment in Pure Sunfarms to its fair value at the acquisition date. The accounting for the business combination was considered complete for the year ended December 31, 2020. The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables $ 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180 The change in goodwill between November 2, 2020 and December 31, 2022 is due to the effect of foreign currency translation. Prior to its acquisition on November 2, 2020, the Company accounted for its investment in Pure Sunfarms, using the equity method. The Company determined that Pure Sunfarms was a variable interest entity (“VIE”), however the Company did not consolidate Pure Sunfarms because the Company was not the primary beneficiary. Although the Company was able to exercise significant influence over the operating and financial policies of Pure Sunfarms through its then 58.7 % majority interest, the Company shared joint control of the board of directors and therefore was not the primary beneficiary. For the three and nine months ended September 30, 2020, the Company’s equity earnings from Pure Sunfarms were $ 1,443 and $ 5,437 , respectively. On March 2, 2020, pursuant to the Settlement Agreement, Emerald transferred to the Company 2.5 % of additional equity in Pure Sunfarms. The Company determined the fair value of the equity received from Emerald to be C$ 6.5 million (US$ 4.7 million). The Company recorded this amount as a gain and included it as a gain on settlement agreement on the Consolidated Statement of Income (Loss) and Comprehensive Income (Loss) for the year ended December 31, 2020. For the period January 1, 2020 to November 1, 2020, the Company's share of the joint venture consisted of the following: Balance, January 1, 2020 $ 41,334 Investments in joint venture 16,393 Share of net income for the year 4,980 Balance, November 1, 2020 $ 62,707
Balanced Health Botanicals
Business Acquisition [Line Items]
Acquisitions	7. BHB ACQUISITION On August 16, 2021 , the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”), by and among Village Farms, Balanced Health and the other parties thereto, including the members of Balanced Health (collectively, the “BHB Sellers”). The Purchase Agreement provided for the acquisition of a 100 % interest in Balanced Health (the “Balanced Health Acquisition”), for a total purchase price comprised of a cash purchase price of approximately $ 30 million, and an aggregate of 4,707,113 of our Common Shares, with a fair value of approximately $ 42 million, issued to the BHB Sellers on the closing date of the Balanced Health Acquisition (the “Closing Date”). In connection with the Balanced Health Acquisition, each of the BHB Sellers entered into a lock-up agreement with us, pursuant to which each such BHB Seller has agreed not to resell the Village Farms Common Shares received as consideration in the Balanced Health Acquisition until such Common Shares cease to be “Restricted Shares” (as defined in the Purchase Agreement) (“Restricted Shares”). Under the terms of the Purchase Agreement and the lock-up agreements, such Common Shares cease to be Restricted Shares, as follows: (i) with respect to one-fourth ( 1/4 ) of such Common Shares, on the Closing Date; (ii) with respect to an additional one-fourth ( 1/4 ) of such Common Shares, on the last day of the four (4) month period following the Closing Date; (iii) with respect to an additional one-fourth ( 1/4 ) of such Common Shares, on the last day of the eight (8) month period following the Closing Date; and (iv) with respect to an additional one-fourth ( 1/4 ) of such Common Shares, on the last day of the twelve (12) month period following the Closing Date. The acquisition was deemed a business combination and the purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. The Company used information available to make fair value determinations of acquired intangible assets. The estimated fair value of the brand was determined using the relief-from-royalty method. This method assumes that the brand has value to the extent that their owner is relieved of the obligation to pay royalties for the benefits received from them. This method requires the Company to estimate the future revenues for the related brand, the appropriate royalty rate, and an asset specific discount rate. This measure of fair value requires significant judgment about the value a market participant would be willing to pay to achieve the benefits associated with the brand. Based upon estimates, the Company identified goodwill of $ 60,008 and a brand intangible of $ 9,250 . This goodwill was calculated as the difference between the fair value of the consideration issued for the acquisition of Balanced Health and the estimated fair value of all assets and liabilities acquired. The goodwill has been allocated to the U.S. Cannabis reporting segment. The accounting for the business combination was complete as of December 31, 2021. The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 30,000 Village Farms common shares issued 4,707,113 $ 8.87 41,752 Working capital adjustment ( 2 ) Total fair value of consideration $ 71,750 August 16, 2021 ASSETS Cash and cash equivalents $ 4,056 Trade and other receivables, net 1,030 Inventories 1,796 Prepaid expenses and deposits 667 Property, plant and equipment 1,900 Right-of-use asset 5,099 Goodwill 60,008 Intangibles 9,394 Other assets 362 Total assets 84,312 LIABILITIES Trade payables 688 Accrued liabilities 6,659 Other current liabilities 192 Lease liability 5,023 Total liabilities 12,562 Net assets acquired 71,750

Rose Acquisition

Rose Acquisition	12 Months Ended
	Dec. 31, 2022
Business Acquisition [Line Items]
Acquisitions	6. PURE SUNFARMS ACQUISITION O n November 2, 2020 , Village Farms consummated a definitive purchase and sale agreement with Emerald Health Therapeutics Inc. (“Emerald”) , acquiring 36,958,500 Common Shares in the capital of Pure Sunfarms owned by Emerald, and increasing Village Farms’ ownership of Pure Sunfarms to 100 %. The shares were acquired for a total purchase price of C$ 79.9 million (US$ 60.0 million), satisfied through an initial C$ 60.0 million (US$ 45.0 million) cash payment and a C$ 19.9 million (US$ 15.0 million) secured promissory note payable to Emerald, which was repaid in full on February 8, 2021. The acquisition was deemed a business combination and the purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values at the date of acquisition. The Company used information available to make fair value determinations and engaged independent valuation specialists to assist in the fair value determination of acquired intangible assets. The estimated fair value of licenses was determined using a multi-period excess earnings method. This earnings-based method considers the net present value of the licenses’ cash flows discounted at an asset specific discount rate. The net present value attributable to the licenses deducts the contributory asset charges used in connection with the licenses. The estimated fair value of the brand was determined using the relief-from-royalty method. This method assumes that the brand has value to the extent that their owner is relieved of the obligation to pay royalties for the benefits received from them. This method requires the Company to estimate the future revenues for the related brand, the appropriate royalty rate, and an asset specific discount rate. This measure of fair value requires significant judgment about the value a market participant would be willing to pay to achieve the benefits associated with the brand. Acquired property, plant and equipment and software were valued using the replacement cost method, which requires the Company to estimate the costs to construct an asset of equivalent utility at prices available at the time of the valuation analysis, with adjustments in value for physical deterioration and functional and economic obsolescence. Upon the acquisition of Pure Sunfarms, the Company identified goodwill of C$ 30,618 (US$ 22,596 ). This goodwill was calculated as the difference between the fair value of the consideration issued for the acquisition of Pure Sunfarms and the fair value of all assets and liabilities acquired. The goodwill is attributable to the acquired workforce and potential for growth through the conversion of the Delta 1 greenhouse facility and future accretive acquisitions. The Company is required to record a deferred tax liability for the difference between the assigned values and the tax bases of assets acquired and liabilities assumed. None of the goodwill is deductible for tax purposes. As a result of the acquisition, the Company also recognized a gain of $ 23.6 million due to the revaluation of its previously held investment in Pure Sunfarms to its fair value at the acquisition date. The accounting for the business combination was considered complete for the year ended December 31, 2020. The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables $ 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180 The change in goodwill between November 2, 2020 and December 31, 2022 is due to the effect of foreign currency translation. Prior to its acquisition on November 2, 2020, the Company accounted for its investment in Pure Sunfarms, using the equity method. The Company determined that Pure Sunfarms was a variable interest entity (“VIE”), however the Company did not consolidate Pure Sunfarms because the Company was not the primary beneficiary. Although the Company was able to exercise significant influence over the operating and financial policies of Pure Sunfarms through its then 58.7 % majority interest, the Company shared joint control of the board of directors and therefore was not the primary beneficiary. For the three and nine months ended September 30, 2020, the Company’s equity earnings from Pure Sunfarms were $ 1,443 and $ 5,437 , respectively. On March 2, 2020, pursuant to the Settlement Agreement, Emerald transferred to the Company 2.5 % of additional equity in Pure Sunfarms. The Company determined the fair value of the equity received from Emerald to be C$ 6.5 million (US$ 4.7 million). The Company recorded this amount as a gain and included it as a gain on settlement agreement on the Consolidated Statement of Income (Loss) and Comprehensive Income (Loss) for the year ended December 31, 2020. For the period January 1, 2020 to November 1, 2020, the Company's share of the joint venture consisted of the following: Balance, January 1, 2020 $ 41,334 Investments in joint venture 16,393 Share of net income for the year 4,980 Balance, November 1, 2020 $ 62,707
Rose Acquisition [Member]
Business Acquisition [Line Items]
Acquisitions	. ROSE ACQUISITION On November 15, 2021 , the Company entered into a Share Purchase Agreement (the “Purchase Agreement”), with Rose and other parties, including the shareholders of Rose (collectively, the “Rose Sellers”), for the acquisition of a 70 % interest in Rose pursuant to the terms of the Purchase Agreement (the “Acquisition”), for a total purchase price (the “Purchase Price”) of C$ 46.7 million, comprised of a cash purchase price of C$ 19.9 million and a total of 2,411,280 Common Shares of Village Farms (“Village Farms Shares”), subject to customary purchase price adjustments. The Village Farms Shares issued under the Purchase Agreement are subject to lock-up agreements, and subject to compliance with applicable securities laws, 33 % of these shares were released from lock-up restrictions four (4) months following the Closing Date, another 33 % of these shares were be released from lock-up restrictions eight (8) months after the Closing Date and the remaining shares were be released from lock-up restrictions one (1) year after the Closing Date. Under the terms of the Purchase Agreement, the Company filed a prospectus supplement under our existing shelf registration statement on March 15, 2022 to register for resale all of the Village Farms Shares issued to the Rose Sellers on the Closing Date . Put/Call Option Two of the co-founders of Rose (the “Management Shareholders”), who were among the Rose Sellers of Rose in the Acquisition, have remained in their current roles with Rose post-Acquisition and have retained a non-voting 30 % interest in Rose (the “Retained Interest”). In conjunction with the Acquisition, Village Farms and the Management Shareholders have entered into a unanimous shareholders agreement (the “USA”) providing Village Farms with a call option to acquire the Retained Interest between December 31, 2024 and March 31, 2025 or upon the occurrence of certain liquidity events with respect to Village Farms (the “Call Option”). As part of the Call Option, Village Farms can also acquire 34 % of the Retained Interest between December 31, 2023 and March 31, 2024. A put right has also been granted to the Management Shareholders to require Village Farms to complete the acquisition of the Retained Interest upon their death or disability or the occurrence of certain liquidity events with respect to Village Farms (the “Put Option”, and together with the Call Option, the “Put/Call Option”). The price for the Put/Call Option was set at a multiple solely based on Rose’s adjusted EBITDA performance of the applicable prior calendar year. If exercised upon a liquidity event, the Option Price is subject to a minimum amount which varies depending on the year on which it is exercised. The consideration for the acquisition of the Retained Interest may, at Village Farms’ sole discretion, be payable solely in cash or in a pre-determined combination of cash and Village Farms shares based on a formula similar to that used for the issuance of the Village Farms shares comprising part of the Purchase Price. The Company finalized the accounting for this business combination on September 30, 2022 which resulted in the Company recognizing goodwill of C$ 30,673 (US$ 24,133 ) and a customer relationship intangible asset of C$ 18,010 (US$ 14,170 ), which is amortizable over 10 years. The Company recognized amortization of $ 1,500 during the year ended December 31, 2022. The estimated fair value of the customer relationship was determined using a multi-period excess earnings method (MEEM"), which is an income approach that is based on the principal that the value of an intangible asset is equal to the net present value of the incremental after-tax cash flows attributable to the customer relationship specific cash flows. The MEEM utilizes current cash flow projections and seeks to isolate the excess stream of earnings that can be attributed to the particular intangible asset. This method requires the Company to estimate the future cash flows for the related customer relationship and an asset specific discount rate. This measure of fair value requires significant judgment about the value a market participant would be willing to pay to achieve the benefits associated with the customer relationship. The Company also recognized a redeemable non-controlling interest classified as temporary mezzanine equity of $ 16,479 . The goodwill and intangible asset have been allocated to the Canadian Cannabis reporting segment. Consideration paid Shares Share Price Amount Cash $ 15,859 Village Farms common shares issued 2,411,280 $ 9.04 21,798 Working capital adjustment $ 1,055 Total fair value of consideration $ 38,712 November 15, 2021 ASSETS Cash and cash equivalents $ 1,118 Trade and other receivables, net 1,595 Inventories 3,586 Prepaid expenses and deposits 498 Property, plant and equipment 16,423 Goodwill 24,133 Intangible assets 14,170 Total assets 61,523 LIABILITIES Trade payables 774 Accrued liabilities 1,803 Deferred tax liability 3,755 Total liabilities 6,332 Mezzanine equity 16,479 Total liabilities and mezzanine equity 22,811 Net assets acquired $ 38,712

Asset Acquisition

Asset Acquisition	12 Months Ended
	Dec. 31, 2022
Asset Acquisition [Abstract]
Asset Acquisition	9. ASSET ACQUISITION Leli Holland B.V. ("Leli") In September 2021, the Company entered into an option agreement whereby the Company received the irrevocable right to acquire an 80 % ownership interest (the “Option Agreement”) in Netherlands-based Leli Holland B.V. (“Leli”) upon payment of EUR 50,000 (the “Option”). The Option Agreement allowed for the Company to acquire 80 % of Leli’s shares for EUR 3,950,000 , of which EUR 950,000 was due and payable to Leli’s shareholders upon the exercise of the Option and the remainder due in three equal installments subject to the achievement of certain project development milestones. The option was exercisable at the sole discretion of the Company. On July 7, 2022, Leli received a license to cultivate cannabis legally in the Netherlands under the Dutch Closed Supply Chain Experiment program ("the Program"). On July 19, 2022, the Company exercised the Option to purchase 80 % of Leli, plus an additional 5 % interest, for total cash consideration of $ 4,693 . The acquisition has been accounted for as an asset acquisition and the full consideration paid has been allocated to the license and accounted for as an intangible asset that will be amortized over a period of 5 years which is consistent with the term of the program. There were no other assets or liabilities acquired in the acquisition.

Investments

Investments	12 Months Ended
	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
Investments	10. INVESTMENTS Altum On February 10, 2022, the Company entered into an AUD 1 million (US$ 719 ) convertible promissory note with Altum (the “Note”). Interest accrues at a rate of 12 % per annum, calculated monthly. Unless earlier repaid, or converted into ordinary shares of Altum, the principal and accrued interest of the Note will be due and payable on August 10, 2023 . As of December 31, 2022, the balance of the Note including accrued interest was $ 791 . Village Fields Hemp USA LLC The net assets of VF Hemp were $ 0 and ($ 10,369 ) as of December 31, 2022 and 2021, respectively. The net loss for the years ending December 31, 2022 and 2021 was $ 2,668 and $ 474 . Included in the losses for the year ended December 31, 2022, is a loss of $ 2,284 which represents the Company’s share of losses from the impairment of inventory at VF Hemp. In conjunction with the inventory write-off, the Company also wrote-off the remaining balance of its loan to VF Hemp in the amount of $ 592 , which has been recorded as a loss on joint venture loan in the condensed consolidated statement of loss and comprehensive loss for the year ended December 31, 2022.

Goodwill and Intangibles Assets

Goodwill and Intangibles Assets	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangibles Assets	. GOODWILL AND INTANGIBLES ASSETS At the end of each reporting period, the Company assesses whether events or changes in circumstances have occurred that would indicate an impairment. The Company considers external and internal factors, including overall financial performance and relevant entity-specific factors, as part of this assessment. Throughout 2022, the Company recognized macroeconomic challenges, decreases in market capitalization, decreases in transaction multiples, and continued ambiguity in federal regulations with respect to the U.S. CBD market. As of June 30, 2022, when the Company considered these qualitative factors in assessing impairment indicators it concluded that the Company's U.S. - Cannabis segment more likely than not was impaired. The Company tested that segment’s assets, including goodwill and intangible assets for impairment. Cannabis - U.S. - Goodwill The recoverable amount of the reporting unit was determined based on a transaction multiple of somewhat similar CBD-based companies. Management concluded that as of June 30, 2022, the recoverable amount was lower than its carrying amount and as a result, an impairment charge to goodwill of $ 25,169 was allocated to the reporting unit. The significant assumptions applied to the determination of the recoverable amount are described below: • Transaction multiples: A market-based revenue multiple of 1.6 x was utilized to determine the recoverable amount. A decrease in the multiple of .25 x, would increase the impairment to goodwill by $ 7,000 . Cannabis - U.S. - Brand The recoverable amount of the brand was determined based on a discounted cash flow projection. Specifically, the Company utilized a relief from royalty valuation technique to arrive at the recoverable amount of the brand. Management concluded that as of June 30, 2022, the recoverable amount was lower than its carrying value of $ 9,250 and as a result, an impairment charge to the brand intangible of $ 4,630 was allocated to the reporting unit. The significant assumptions applied to the determination of the recoverable amount are described below: • Post-tax discount rate: A market participant post-tax discount rate applied to the after-tax forecast cash flows was 11 %. An increase of 1 % to the discount rate, would increase the impairment by approximately $ 530 . • Royalty rate: An incremental royalty rate of 4.0 % of revenues was applied to brand-specific revenues. A decrease to the incremental royalty rate by 0.5 % would increase the impairment to brand by $ 1,490 . • Future revenues: A decrease in future revenues by 10 % would increase the impairment by approximately $ 470 . As of December 31, 2022, the Company performed its annual impairment test using a quantitative test to assess the recoverability of goodwill and intangible assets for its Cannabis – U.S. and Cannabis – Canada reporting units. Cannabis - Canada - Goodwill The recoverable amount of the reporting unit was determined based on a discounted cash flow projection from budgets approved by senior management covering a three-year period. Management concluded that the recoverable amount was higher than its carrying amount by approximately $ 17,196 as of December 31, 2022 and therefore no impairment to goodwill was required. The significant assumptions applied to the determination of the recoverable amount are described below: • Post-tax discount rate: An increase in 0.5 % in the discount rate would result in the recoverable amount being equal to the carrying value, and each additional 1 % increase would result in an additional impairment of approximately $ 29,299 . • Terminal growth rate: A decrease in 0.7 % in the terminal growth rate would result in the recoverable amount being equal to the carrying value, and each additional 1 % decrease would result in an additional impairment of approximately $ 18,229 . • Future cash flows: A decrease in the future cash flows by 5.5 % would result in the recoverable amount being equal to the carrying value, and each additional 5.0 % decrease would result in an additional impairment of approximately $ 15,126 . Cannabis - Canada - Brand The recoverable amount of the brand was determined based on a discounted cash flow projection, covering a three-year period Specifically, the Company utilized a relief from royalty valuation technique to arrive at the recoverable amount of the brand. Management concluded that the recoverable amount was higher than its carrying value of $ 3,420 by approximately $ 1,033 as of December 31, 2022 and therefore, no impairment to brand was allocated to the reporting unit. The significant assumptions applied to the determination of the recoverable amount are described below: • Royalty rate: An incremental royalty rate of 3.50 % of revenues was applied to brand-specific revenues. A decrease to the incremental royalty rate by 0.50 % would result in an impairment of approximately $ 3,469 . • Post-tax discount rate: An increase in the discount rate by 2 % would result in the recoverable amount being equal to the carrying value, and each additional 1 % increase in the discount rate would result in an impairment of approximately $ 308 . • Future revenues: A decrease in future revenues by 20 % would result in the recoverable amount being equal to the carrying value. Any further decreases to the future revenues would result in the value of the brand written down to $ nil . Cannabis - Canada - Definite-Lived Intangible At December 31, 2022, the Company also evaluated the recoverability of its definite-lived intangible assets which includes customer relationship and license intangibles. The Company concluded the undiscounted cash flows of the asset group exceeded its carrying value of $ 24,969 at December 31, 2022 and therefore no impairment to the definite-lived intangibles was required. Cannabis - U.S.- Goodwill The recoverable amount of the reporting unit was determined based on a discounted cash flow projection from budgets approved by senior management covering a three-year period. Management concluded that as of December 31, 2022, the recoverable amount was lower than its carrying amount and as a result, an impairment charge to goodwill of $ 13,500 was allocated to the reporting unit. The significant assumptions applied to the determination of the recoverable amount are described below: • Post-tax discount rate: A market participant post-tax discount rate applied to the after-tax forecast cash flows was 10 %, which reflects market participant assumptions. An increase of 1 % to the discount rate, would increase the impairment to goodwill by $ 4,100 . • Terminal growth rate: The forecast cash flows beyond a three-year period are extrapolated using a 4.1 % growth rate. A decline of 1 % in the terminal growth rate, would increase the impairment to goodwill by $ 2,900 . • Future cash flows: A decrease in future cash flows by 10 % would increase the impairment by approximately $ 2,500 . U.S. Cannabis - Brand The recoverable amount of the brand was determined based on a discounted cash flow projection. Specifically, the Company utilized a relief from royalty valuation technique to arrive at the recoverable amount of the brand. Management concluded the recoverable amount was higher than its carrying value of $ 4,620 by approximately $ 380 as of December 31, 2022, and therefore, no impairment charge to the brand was allocated to the reporting unit. The significant assumptions applied to the determination of the recoverable amount are described below: • Royalty rate: An increase to the incremental royalty rate of 0.05 % would result in the recoverable amount being equal to the carrying value, and each additional 0.5 % decrease would result in an additional impairment of approximately $ 3,320 . • Future revenues: A decrease in future revenues by 8 % would result in the recoverable amount being equal to the carrying value, and each additional decrease of 5 % would result in an impairment of $ 220 . • Post-tax discount rate: An increase in the discount rate of 0.5 % would result in the recoverable amount being equal to the carrying value, and each increase of 0.5 % would result in an additional impairment of $ 420 . Goodwill The following table presents the changes in the carrying value of goodwill by reportable segment: Cannabis - Canada Cannabis - United States Total Balance as of December 31, 2021 $ 57,525 $ 60,008 $ 117,533 Purchase price adjustment 3,755 — 3,755 Reclassification to intangible assets ( 14,170 ) — ( 14,170 ) Foreign currency translation adjustment ( 2,224 ) — ( 2,224 ) Impairments — ( 38,669 ) ( 38,669 ) Balance as of December 31, 2022 $ 44,886 $ 21,339 $ 66,225 Intangible Assets Intangibles consisted of the following: Classification December 31, 2022 December 31, 2021 Licenses $ 17,691 $ 12,835 Brand and trademarks* 12,719 12,951 Customer relationships 13,291 — Computer software 1,955 2,014 Other* 144 144 Less: Accumulated amortization ( 4,013 ) ( 1,550 ) Less: Impairments ( 4,630 ) — Intangibles, net $ 37,157 $ 26,394 *Indefinite-lived intangible assets. The expected future amortization expense for definite-lived intangible assets as of December 31, 2022 is as follows: Fiscal period 2023 $ 3,320 2024 3,186 2025 3,100 2026 3,012 2027 3,012 Thereafter 13,294 Intangibles, net $ 28,924 Amortization expense for intangibles was $ 2,259 , $ 916 and $ 122 for the years ended December 31, 2022, 2021 and 2020, respectively.

Line of Credit and Long-term De

Line of Credit and Long-term Debt	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Line of Credit and Long-term Debt	14. LINE OF CREDIT AND LONG-TERM DEBT Balance outstanding as of December 31, 2022 2021 Term Loan - ("FCC Loan") - repayable by monthly principle of payments of $ 164 and accrued interest at a rate of 7.71 %; matures April 1, 2025 $ 24,755 $ 26,723 Term Loan - VFCE: CA$ 3.0 M - non-revolving fixed rate loan with fixed interest rate of 4.98 %; matures June 2023 — 491 Term Loan - Pure Sunfarms - CA$ 19.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount, interest rate of 8.7 %; matures February 2024 9,664 11,870 Term loan - Pure Sunfarms - CA$ 25.0 - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount starting June 30, 2021 , interest rate of 8.7 %; matures February 2024 14,867 17,806 BDC Facility - Pure Sunfarms - non-revolving demand loan at prime interest plus 3.75 %, matures December 31, 2031 4,181 4,946 Total $ 53,467 $ 61,836 The Company's line of credit ("Operating Loan") had $ 4,000 amount drawn on the facility as of December 31, 2022, while there was no amount drawn as of December 31, 2021. The carrying value of the assets and securities pledged as collateral for the FCC Loan as of December 31, 2022 and 2021 was $ 113,159 and $ 233,187 , respectively. The carrying value of the assets pledged as collateral for the Operating Loan as of December 31, 2022 and 2021 was $ 26,666 and $ 34,741 , respectively. On March 2, 2022, the Company repaid the outstanding balance of the VFCE Term Loan and related advance balance on the term loan. The Pure Sunfarms line of credit had $ 3,529 and $ 7,760 outstanding as of December 31, 2022 and December 31, 2021, respectively. As of December 31, 2022 and December 31, 2021, Pure Sunfarms had an outstanding letter of credit issued to BC Hydro against the revolving line of credit of $C 4,145 . The Company is required to comply with financial covenants, measured either quarterly or annually depending on the covenant. The Company was not in compliance with one financial covenant under the FCC Loan. Prior to December 31, 2022, the Company received a waiver from FCC for the annual test on December 31, 2022 for the one financial covenant. The covenant will be reinstated for fiscal year 2023. FCC measures the Company's financial covenants once a year on the last day of the year. Prior to December 31, 2022 , Pure Sunfarms also received a waiver allowing Pure Sunfarms' fourth quarter inventory write-down, of approximately $ 11.0 million, to be excluded from its December 31, 2022 loan covenant calculations. The waiver was issued pursuant to an amended Term Loan agreement by the bank syndicate. Village Farms was in compliance with all of its remaining covenants under its other credit facilities. The weighted average interest rate on short-term borrowings as of December 31, 2022 and 2021 was 9.12 % and 5.15 %, respectively. Accrued interest payable on the Credit Facilities and loans as of December 31, 2022 and 2021 was $ 398 and $ 304 , respectively, and these amounts are included in accrued liabilities in the statements of financial position. The aggregate annual principal maturities of long-term debt for the next five years and thereafter are as follows: 2023 $ 8,309 2024 25,035 2025 23,190 2026 718 2027 671 Thereafter 2,213 $ 60,136

Accrued Liabilities

Accrued Liabilities	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued Liabilities	12. ACCRUED LIABILITIES December 31, 2022 December 31, 2021 Received not invoiced $ 6,252 $ 3,470 Accrued payroll 2,766 3,552 Accrued grower partner payables 824 2,248 Other 3,222 4,898 $ 13,064 $ 14,168

Leases

Leases	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Leases	13. LEASES The Company leases a parcel of land in Marfa, Texas that one of its greenhouses resides on as well as two distribution centers located in Fort Worth, Texas and Surrey, British Columbia. The Company leases production-related equipment at its greenhouses in Texas and British Columbia. The Company also leases an office building located in Lake Mary, Florida for its corporate headquarters, and office and manufacturing space in Denver, Colorado for BHB’s headquarters and operations. Rose owns land and leases a building for headquarters and operations in Montreal, Quebec. The components of lease related expenses are as follows: Year ended December 31, 2022 2021 Operating lease expense (a) $ 4,434 $ 2,926 Finance lease expense: Amortization of right-of-use assets — 25 Total finance lease expense $ — $ 25 (a) Includes short-term lease costs of $ 999 and $ 680 for the year ended December 31, 2022 and 2021 . Cash paid for amounts included in the measurement of lease liabilities: Year ended December 31, 2022 2021 Operating cash flows from operating leases and finance leases $ 604 $ 1,351 Financing cash flows from finance leases $ — $ 17 December 31, 2022 Weighted average remaining lease term: Operating leases 5.50 Weighted average discount rate: Operating leases 7.47 % Maturities of lease liabilities are as follows: Operating leases 2023 $ 2,616 2024 2,126 2025 1,911 2026 1,958 2027 1,350 Thereafter 2,168 Undiscounted lease cash flow commitments 12,129 Reconciling impact from discounting ( 2,374 ) Lease liabilities on consolidated statement of financial position as of December 31, 2022 $ 9,755

Financial Instruments

Financial Instruments	12 Months Ended
	Dec. 31, 2022
Investments, All Other Investments [Abstract]
Financial Instruments	15. FINANCIAL INSTRUMENTS Financial assets and liabilities are recognized on the consolidated statements of financial position at fair value in a hierarchy for those assets and liabilities measured at fair value on a recurring basis. At December 31, 2022 and 2021, the Company’s financial instruments included cash and cash equivalents, trade receivables, minority investments, trade payables, accrued liabilities, lease liabilities, note payables and debt. The carrying value of cash and cash equivalents, trade receivables, trade payables, and accrued liabilities approximate their fair values due to the short-term maturity of these financial instruments. The carrying value of lease liabilities, notes payable, and debt approximate their fair values due to insignificant changes in credit risk. There were no financial instruments categorized as Level 3 at December 31, 2022 and December 31, 2021 , other than the minority investments discussed below. There were no transfers of assets or liabilities between levels during the years ended December 31, 2022 and 2021, respectively. For its investments, the Company has elected the practicability election to fair value measurement, under which the investment is measured at cost, less impairment, plus or minus any observable price changes of an identical or similar investment.

Commitments And Contingencies

Commitments And Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	16. COMMITMENTS AND CONTINGENCIES In the normal course of business, the Company and its subsidiaries may become defendants in certain employment claims and other litigation. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. The Company is not involved i n any legal proceedings other than routine litigation arising in the normal course of business, none of which the Company believes will have a material adverse effect on the Company’s business, financial condition or results of operations.

Related Party Transactions and

Related Party Transactions and Balances	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transaction and Balances	17. RELATED PARTY TRANSACTIONS AND BALANCES On March 25, 2019, the Company entered into a Grid Loan Agreement (the “Grid Loan”) with VF Hemp. As of December 31, 2022, and December 31, 2021 the Grid Loan balance was $ 0 and $ 3,256 , respectively. One of the Company’s employees is related to a member of the Company’s executive management team and received approximately $ 115 , $ 114 and $ 118 in salary and benefits during the years ended December 31, 2022, 2021 and 2020 , respectively.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	18. INCOME TAXES The components of the provision for (recovery of) income tax for the years ended December 31, 2022, 2021 and 2020 are as follows: 2022 Current Deferred Total US Federal $ — $ 14,650 $ 14,650 US State 72 ( 2,085 ) ( 2,013 ) Canadian ( 5,222 ) ( 2,734 ) ( 7,956 ) $ ( 5,150 ) $ 9,831 $ 4,681 2021 Current Deferred Total US Federal $ — $ ( 3,278 ) $ ( 3,278 ) US State 135 ( 176 ) ( 41 ) Canadian ( 795 ) 588 ( 207 ) $ ( 660 ) $ ( 2,866 ) $ ( 3,526 ) 2020 Current Deferred Total US Federal $ — $ ( 4,879 ) $ ( 4,879 ) US State 260 ( 434 ) ( 174 ) Canadian 3,412 ( 1,149 ) 2,263 $ 3,672 $ ( 6,462 ) $ ( 2,790 ) The (recovery of) provision for income taxes reflected in the consolidated statements of (loss) income for the years ended December 31, 2022, 2021 and 2020 differs from the amounts computed at the federal statutory tax rates. The principal differences between the statutory income tax (recovery) and the effective provision for (recovery of) income taxes are summarized as follows: Year Ended December 31, 2022 2021 2020 (Loss) income before income taxes $ ( 96,734 ) $ ( 12,651 ) $ 8,818 Tax (recovery) calculated at US domestic tax rates ( 20,339 ) ( 2,592 ) 1,869 State tax adjustments ( 1,799 ) ( 230 ) ( 310 ) Non-deductible items 928 1,516 ( 6,531 ) True up of prior year income tax estimates — ( 648 ) ( 181 ) Share of income from joint venture — — ( 228 ) Deferred adjustment ( 3,324 ) ( 2,429 ) 343 Tax rate differences on deferred items 308 397 49 Foreign rate differentials 88 86 1,643 Change in tax rates 5 5 37 Change in valuation allowance 28,684 57 3 Other 130 312 516 Recovery of income taxes $ 4,681 $ ( 3,526 ) $ ( 2,790 ) The statutory tax rate in effect in Canada and the United States for the year ended December 31, 2022, 2021 and 2020 was 27.0 % and 21.0 %, respectively. The blended effective tax rate for 2022 was ( 4.8 %) compared to 27.9 % and ( 31.4 %) in 2021 and 2020, respectively. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The deferred tax assets and liabilities presented on the consolidated statements of financial position are net amounts corresponding to their reporting jurisdiction. The deferred tax assets and liabilities presented in the note disclosure are grouped based on asset and liability classification without consideration of their corresponding reporting jurisdiction. Significant components of the Company’s net deferred income taxes at December 31, 2022 and 2021 are as follows: 2022 2021 Deferred tax assets: Other assets $ 5,536 $ 5,140 Long-term debt 943 832 Tax losses: Non-capital and farm losses 33,579 22,860 Provisions: Debt and unit issuance costs 1,683 2,194 Tax losses: Valuation allowance ( 30,419 ) ( 1,708 ) 11,322 29,318 Deferred tax liabilities: Joint venture shares ( 2,406 ) ( 2,662 ) Cash adjustment ( 12,861 ) ( 11,514 ) Property, plant and equipment ( 11,610 ) ( 17,033 ) ( 26,877 ) ( 31,209 ) Net tax assets $ ( 15,555 ) $ ( 1,891 ) In assessing the ability to realize deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon available positive and negative evidence and future taxable income, the Company has record ed a $ 30,419 valu ation allowance on its deferred tax assets for the year ended December 31, 2022 . The valuation allowance reflected on the consolidated balance sheet is $ 1,708 at December 31, 2021. Included in the schedule of deferred tax assets and liabilities above are US federal net operating loss carryforwards of approxim ately $ 106,428 and $ 74,607 as of December 31, 2022 and 2021 , respectively, which will begin to expire in 2031 . At the state level, the Company has a combined state net operating loss carry forwards of approximately $ 42,768 and $ 28,189 as of December 31, 2022 and 2021 , respectively, which started to expire in 2022 . The Canadian Federal Non-Capital Loss carry forwards are $ 43,829 and $ 26,916 as of December 31, 2022 and 2021 , respectively. The Canadian Provincial Non-Capital Loss carry forwards are $ 15,974 and $ 13,409 , as of December 31, 2022 and 2021, respectively. At December 31, 2022 and 2021, the balance of uncertain tax benefits i s zero . The Company does not anticipate that the amount of the uncertain tax benefit will significantly increase within the next 12 months. The Company recognizes accrued interest related to uncertain tax benefits and penalties as income tax expense. As of December 31, 2022 and 2021 , there are no recognized liabilities for interest or penalties. The Company is subject to taxation in the U.S. and various states, as well as Canada and its provinces. As of December 31, 2022 , the Company’s tax years for 2019, 2020 and 2021 are subject to examination by the tax authorities. With few exceptions, as of December 31, 2022, the Company is no longer subject to U.S. federal, state or local examinations by tax authorities for years before 2019.

Segment and Geographic Informat

Segment and Geographic Information	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segment and Geographic Information	19. SEGMENT AND GEOGRAPHIC INFORMATION Segment reporting is prepared on the same basis that the Company’s Chief Executive Officer, who is the Company’s Chief Operating Decision Maker, manages the business, makes operating decisions and assesses performance. Management has determined that the Co mpany operates in four segments. The Company’s four segments include Produce, Cannabis-Canada, Cannabis-U.S. and Energy. Th e Produce segment produces, markets and sells premium quality tomatoes, bell peppers and cucumbers. The Cannabis-Canada segment produces and supplies cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally. The Cannabis-U.S. segment develops and sells high-quality, CBD-based health and wellness products including ingestible, edible and topical applications. The Energy business produces power that it sells pursuant to a long-term contract to its one customer. For years ended December 31, 2022, 2021 and 2020, approximately 51 %, 48 % and 79 %, respectively, of the Company’s total sales were in the United States. I n 2022, the Company had one customer that individually represented more than 10 % of total sales, comprising of 14.6 %. In 2021, the Company had two customers that individually represented more than 10 % of its sales, comprising of 20.1 % and 10.6 % of sales, respectively. In 2020, the Company had two customers that individually represented more than 10 % of its sales, comprising of 12.7 % and 12.5 % of sales, respectively. As of December 31, 2022, the Company’s trade receivables had one customer that represented more than 10 % of the balance of trade receivables, representing 19.1 % of the balance. As of December 31, 2021, the Company’s trade receivables had one customer that represented more than 10 % of the balance of trade receivables, representing 29.0 % of the balance. As of December 31, 2020, the Company’s trade receivables had two customers that represented more than 10 % of the balance of trade receivables, representing 26.3 % of the balance. The Company’s primary operations are in the United States and Canada. Segment information as of and for the years ended December 31, 2022, 2021 and 2020: 2022 2021 2020 Sales Produce $ 160,252 $ 159,778 $ 156,891 Cannabis – Canada 109,882 96,434 12,778 Cannabis – United States 23,302 11,345 — Energy 136 463 417 $ 293,572 $ 268,020 $ 170,086 Interest expense Produce $ 1,472 $ 561 $ 1,759 Cannabis – Canada 1,768 2,236 243 Cannabis – United States — 1 — Energy 4 37 54 $ 3,244 $ 2,835 $ 2,056 Interest income Corporate $ 196 $ 117 $ 623 Cannabis – Canada 11 9 2 $ 207 $ 126 $ 625 Depreciation and amortization Produce $ 5,044 $ 5,238 $ 5,356 Cannabis – Canada 7,445 5,875 822 Cannabis – United States 565 299 — Energy — 1,297 647 $ 13,054 $ 12,709 $ 6,825 Gross margin Produce $ ( 17,382 ) $ 1,474 $ 9,621 Cannabis – Canada 29,388 37,209 2,193 Cannabis – United States 15,659 7,947 — Energy ( 168 ) ( 1,451 ) ( 854 ) $ 27,497 $ 45,179 $ 10,960 Total assets 2022 2021 United States $ 113,497 $ 116,654 Canada 346,126 450,257 Netherlands 5,662 — $ 465,285 $ 566,911 Property, plant and equipment, net 2022 2021 United States $ 37,780 $ 39,583 Canada 169,921 176,121 $ 207,701 $ 215,704

(Loss) Income Per Share

(Loss) Income Per Share	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
(Loss) Income Per Share	20. (LOSS) INCOME PER SHARE Basic net (loss) income per share is computed using the weighted average number of Common Shares outstanding for the period. Basic and diluted net income per ordinary share is calculated as follows: For the Years Ended December 31, (shares in thousands) 2022 2021 2020 Numerator: Net (loss) income including non-controlling interests $ ( 101,415 ) $ ( 9,125 ) $ 11,608 Less: Net loss attributable to non-controlling interests $ 269 $ 46 $ — Net (loss) income attributable to Village Farms International, Inc. shareholders $ ( 101,146 ) $ ( 9,079 ) $ 11,608 Denominator: Weighted average number of common shares – basic 89,127 82,161 58,526 Effect of dilutive securities – share-based employee options and awards — — 2,964 Weighted average number of common shares – diluted 89,127 82,161 61,490 Anti-dilutive options and awards (1) 4,089 3,822 500 Net (loss) income per ordinary share: Basic $ ( 1.13 ) $ ( 0.11 ) $ 0.20 Diluted $ ( 1.13 ) $ ( 0.11 ) $ 0.19 (1) Options to purchase shares of common stock and unvested RSUs are not included in the calculation of net (loss) income per share because the effect would have been anti-dilutive.

Shareholders' Equity and Share

Shareholders' Equity and Share Based Compensation	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Shareholders' Equity and Share Based Compensation	21. SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION On August 9, 2022, Village Farms entered into a Controlled Equity Offering Sales Agreement ("Sales Agreement") pursuant to which the Company may offer and sell Common Shares having an aggregate offering price up to $ 50 million from time to time to or through Cantor Fitzgerald & Co. and A.G.P./Alliance Global Partners. Under the Sales Agreement, the Company may offer and sell Common Shares through Cantor Fitzgerald & Co. and A.G.P./Alliance Global Partners by any method deemed to be an “at the market offering” as defined in Rule 415 of the Securities Act of 1933, as amended, including sales made directly on The Nasdaq Capital Market. As of December 31, 2022, the Company had issued and sold 3,175,000 Common Shares under the Sales Agreement, resulting in net proceeds of $ 6,692 after deducting commissions and offering expenses. On September 10, 2020, the Company sold 9,396,226 units through a registered direct offering. Each unit that was sold consisted of one common share of the Company and one-half (0.5) of a warrant to purchase a common share of the Company at a price of $ 5.80 . On March 10, 2021 , the warrants became exercisable and will expire on September 10, 2025 . As of December 31, 2022, 3,188,680 of the warrants have been exercised. ASC 480, Distinguishing Liabilities from Equity , requires that these warrants are classified as equity. The fair value of these warrants was determined using the Black-Scholes-Merton valuation model. The Company’s Share-Based Compensation Plan (the “Plan”) dated January 1, 2010, was most recently approved by Shareholders on June 10, 2021. The Plan provides that the number of Common Shares reserved for issuance upon the exercise or redemption of awards granted under the Plan is a rolling maximum of ten percent ( 10 %) of the outstanding Common Shares at any point in time. Approximately 5,069 shares remain available for issuance of December 31, 2022. Stock options have been granted with an exercise price equal to the fair market value of the common stock on the date of grants and have a ten-year contractual term. The stock options vest ratably over a 3 - year period. Compensation expense is recognized on a straight-line basis. The fair market value of stock options is estimated using the Black-Scholes-Merton valuation model and the Company uses the following methods to determine its underlying assumptions: expected volatilities are based on the historical volatilities of the weekly closing price of the Company’s common stock; the expected term of options granted is based historical exercises and forfeitures; the risk-free interest rate is based on Canadian Treasury bonds issued with similar life terms to the expected life of the grant; and the expected dividend yield is based on the current annual dividend amount divided by the stock price on the date of grant. Forfeitures are recorded when incurred. The following key assumptions were used in the valuation model to value stock option grants for each respective period: 2022 2021 2020 Expected volatility 84.0 % - 89.9 % 68.3 % - 75.7 % 71.1 % Dividend $nil $nil $nil Risk-free interest rate 1.41 % - 3.28 % 1.07 % - 1.54 % 0.52 % Expected life 6.5 years 4.5 years - 6.9 years 7.1 years Fair value $ 0.93 - $ 4.33 $ 4.29 - $ 7.31 $ 4.65 Stock option transactions under the Company’s plan for the years ended December 31, 2022, 2021 and 2020 are summarized as follows: Number of Weighted Weighted Aggregate Outstanding at January 1, 2020 2,452,666 $ 3.93 5.60 $ 8,784 Granted during 2020 1,081,488 $ 6.54 9.75 $ 254 Exercised during 2020 ( 425,166 ) $ 1.01 1.62 $ 2,039 Forfeited/expired during 2020 ( 41,666 ) $ 5.17 Outstanding at December 31, 2020 3,067,322 $ 5.42 6.82 $ 15,735 Exercisable at December 31, 2020 1,618,168 $ 3.07 4.58 $ 11,865 Granted during 2021 792,236 $ 8.47 9.78 $ 57 Exercised during 2021 ( 177,000 ) $ 1.07 1.14 $ 1,813 Forfeited during 2021 ( 60,000 ) $ 10.70 Outstanding at December 31, 2021 3,622,558 $ 6.20 7.89 $ 6,530 Exercisable at December 31, 2021 2,042,663 $ 4.80 5.14 $ 6,001 Granted during 2022 725,360 $ 2.74 9.70 $ 16 Exercised during 2022 ( 180,000 ) $ 1.30 0.51 $ 772 Forfeited during 2022 ( 78,500 ) $ 8.45 Outstanding at December 31, 2022 4,089,418 $ 5.76 6.77 $ 152 Exercisable at December 31, 2022 2,549,401 $ 5.88 5.46 $ 133 The weighted-average grant-date fair value of options granted during the years 2022, 2021 and 2020 was $ 3.31 , $ 6.00 and $ 4.65 , respectively. The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 and 2020, was $ 772 , $ 2,273 and $ 2,732 , respectively. A summary of the status of the Company’s non-vested stock options, and the changes during the year ended December 31, 2022 is presented below: Number of Weighted Aggregate Non-vested at January 1, 2022 1,579,895 $ 5.28 Granted 725,360 $ 2.06 Vested ( 696,238 ) $ 5.35 Forfeited ( 69,000 ) $ 5.75 Non-vested at December 31, 2022 1,540,017 $ 3.72 $ 19 As of December 31, 2022 , there was approximately $ 5,692 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the stock option plan; that cost is expected to be recognized over a period of three years . The Company has also issued performance-based restricted share units to Village Farms employees involved with future developments of the Company. Once a performance target is met and the share units are deemed earned and vested, compensation expense is recognized, based on the fair value of the share units on the grant date. Performance-based restricted share unit activity for the years ended December 31, 2022, 2021 and 2020 is as follows: Number of Weighted Average Outstanding at January 1, 2020 739,000 $ 6.08 Granted 1,068,000 $ 4.75 Issued ( 840,000 ) $ 4.83 Forfeited/expired ( 98,000 ) $ 7.16 Outstanding at December 31, 2020 869,000 $ 5.89 Exercisable at December 31, 2020 75,000 $ 4.79 Granted 158,000 $ 7.72 Exercised ( 487,000 ) $ 5.70 Forfeited ( 310,000 ) $ 6.66 Outstanding at December 31, 2021 230,000 $ 6.83 Exercisable at December 31, 2021 200,000 $ 6.49 Granted — — Exercised ( 200,000 ) $ 6.41 Forfeited/expired — — Outstanding at December 31, 2022 30,000 $ 8.31 Exercisable at December 31, 2022 30,000 $ 8.31 A summary of the status of the Company’s non-vested performance-based restricted share units, and the changes during the year ended December 31, 2022, is presented below: Number of Weighted Average Non-vested at January 1, 2022 30,000 $ 8.24 Vested ( 30,000 ) $ 8.31 Non-vested at December 31, 2022 — — Total share-based compensation expense for the years ended December 31, 2022, 2021 and 2020 of $ 3,987 , $ 7,533 and $ 6,142 , respectively, was recorded in selling, general and administrative expenses and the corresponding amount credited to additional paid in capital.

Changes in Non-Cash Working Cap

Changes in Non-Cash Working Capital Items	12 Months Ended
	Dec. 31, 2022
Disclosure Of Changes In Non Cash Working Capital Items [Abstract]
Changes in Non Cash Working Capital Items	22. CHANGES IN NON-CASH WORKING CAPITAL ITEMS For the Years Ended December 31, 2022 2021 2020 Trade receivables $ 3,310 $ ( 9,914 ) $ ( 3,196 ) Inventories ( 14,583 ) ( 16,761 ) 2,997 Note receivable — — 765 Due from joint ventures — 4 4,363 Other receivables ( 4 ) ( 399 ) 199 Prepaid expenses and deposits 3,815 ( 3,201 ) ( 1,245 ) Trade payables 6,697 6,327 ( 1,665 ) Accrued liabilities 7,805 ( 10,389 ) 6,565 Other assets, net of other liabilities ( 9,286 ) ( 12,816 ) 4,289 $ ( 2,246 ) $ ( 47,149 ) $ 13,072

Subsequent Event

Subsequent Event	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Event	23. SUBSEQUENT EVENT On January 20, 2023, the Company closed a registered direct offering with certain institutional investors for the purchase and sale of an aggregate of 18,350,000 Common Shares at $ 1.35 per common share, together with accompanying warrants to purchase up to 18,350,000 common shares at an exercise price of $ 1.65 . The proceeds from the sale of Common Shares are approximately $ 25 million before placement agent fees and other offering expenses. The warrants will be exercisable beginning on July 30, 2023 and will expire on July 30, 2028 . ASC 480, Distinguishing Liabilities from Equity, requires that these warrants are classified as equity. The fair value of these warrants was determined using the Black-Scholes-Merton valuation model.

Significant Accounting Policies

Significant Accounting Policies, Judgments and Estimation Uncertainty (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	The Consolidated Financial Statements reflect the accounts of the Company and our majority-owned and controlled subsidiaries. All intercompany accounts and transactions between our consolidated operations have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the amounts of assets and liabilities and the disclosures regarding contingent assets and liabilities at period end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material.

Summary Of Significant Accoun_2

Summary Of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Revenue Recognition	Revenue Recognition The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods at a fixed price. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders received from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and their performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. Revenue from the sale of cannabis inventories in the course of ordinary activities is measured at the fair value of the consideration received or receivable, net of returns, trade discounts, volume rebates and excise duty. The Company recognizes revenue when it has fulfilled the performance obligation to the customer through the delivery and transfer of control of the promised goods. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is still in the Company’s physical possession, and title and risk of loss has passed to the customer. Revenue is recognized when all specific requirements for transfer of control under a bill-and-hold arrangement have been met. The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption. The Company has elected to exclude taxes collected from its customers assessed by government authorities that are both imposed on and concurrent with a specific revenue-producing transaction from our determination of transaction price. Direct-to-consumer product sales for loyalty members contain two distinct performance obligations for which the Company allocates the transaction price based on the relative stand-alone value of each performance obligation, such that both revenue related to the delivery of the underlying purchased goods and deferred revenue for loyalty points issued to the customer are recognized based on the allocated consideration of value, after giving consideration to loyalty point breakage. The loyalty liability represents a performance obligation to provide goods for free or at a discount to loyalty members in exchange for the redemptions of points earned from past activities. Judgment is required in determining whether the Company is the principal or agent in certain transactions. We evaluate the presentation of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e. “gross”), or we arrange for other parties to provide the service to the end-user and are an agent (i.e. “net”). Revenue received from shipping and handling fees is reflected in net sales. Shipping and handling costs are included in cost of sales as incurred or at the time revenue is recognized for the related goods, whichever comes first.
Redeemable Non-Controlling Interest	Redeemable Non-Controlling Interest Non-controlling interest (“NCI”) in subsidiaries that are redeemable for cash or other assets outside of our control are classified as temporary mezzanine equity, outside of equity and liabilities. Initial measurement is at acquisition date fair value and subsequent measurement is at the greater of the carrying value or the redemption value. C hanges in the redemption value are recognized immediately as they occur and the carrying amount of the redeemable NCI is adjusted to equal the redemption value at the end of each reporting period. This method views the end of the reporting period as if it were also the redemption date for the instrument. I ncreases or decreases in the estimated redemption amount are recorded with corresponding adjustments against equity and are reflected in the computation of earnings per share. However, the amount presented in temporary equity should be no less than the initial amount reported in temporary equity for the instrument.
Foreign Currency Translation	Foreign Currency Translation Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency at the exchange rates in effect at the reporting date. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated to the functional currency at the exchange rate in effect when the fair value was determined. Foreign currency differences are generally recognized in net income. Non-monetary items that are measured based on historical cost in a foreign currency are translated to the functional currency using the exchange rate in effect at the date of the transaction giving rise to the item.
Income Taxes	Income Taxes The Company uses the asset and liability method of accounting for income taxes. Temporary differences arising between the tax basis of an asset or liability and its carrying amount on the Consolidated Statement of Financial Position are used to calculate future income tax assets and liabilities. This method also requires the recognition of deferred tax benefits, such as net operating loss carryforwards. Valuation allowances are recorded as appropriate to reduce deferred tax assets to the amount considered likely to be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to the taxable income (losses) in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment of the change. A tax benefit from an uncertain tax position is recognized only if we believe it is more likely than not that the position will be sustained on its technical merits. If the recognition threshold for the tax position is met, only the portion of the tax benefit that we believe is greater than 50 percent likely to be realized is recorded.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of cash deposits held with banks, and other highly liquid short-term interest-bearing securities with maturities at the date of purchase of three months or less.
Restricted Cash	Restricted Cash Restricted cash, as of December 31, 2022 and 2021 includes a cash deposit required by the Company’s directors’ and officers’ insurance policy which is managed by an insurer and held as a cell captive within a Bahamas-based financial institution.
Trade Receivables	T rade Receivables Trade receivables, net of the allowance for doubtful accounts, represent their estimated net realizable value, which approximates fair value. Provisions for doubtful accounts are recorded based on historical collection experience and the age of the receivables. Receivables are written off when they are deemed uncollectible.
Inventories	Inventories Inventories are valued at the lower of cost or net realizable value. The cost of inventory includes capitalized production costs, including labor, materials, post-harvest costs and depreciation. Inventoriable costs are expensed to cost of goods sold on the Consolidated Statement of (Loss) Income in the same period as finished products are sold. The amount of any write-down of inventories to net realizable value and all losses of inventories are recognized as an expense in the period when the write-down or loss occurs.
Intangible Assets	Intangible Assets The Company’s intangible assets are purchased and acquired through business combinations and have both finite and infinite useful lives. They are measured at cost less accumulated amortization and any accumulated impairment losses. Amortization is calculated based on the cost of the intangible assets less their estimated residual values using the straight-line method over their estimated useful lives and is generally recognized in profit or loss. Amortization methods, useful lives and residual values are reviewed at each reporting date and adjusted when necessary. Classification Estimated Useful Lives Licenses 5 - 22 years Brand and trademarks Indefinite Customer relationships 10 years Computer software 3 - 5 years
Business Combinations	Business Combinations The Company recognizes and measures the assets acquired and liabilities assumed, including contingent assets and liabilities, at their respective fair values on the date of acquisition. Any excess of the purchase consideration over the net fair value of tangible and identified intangible assets acquired less liabilities assumed is recorded as goodwill. The costs of business acquisitions, including fees for accounting, legal, professional consulting and valuation specialists, are expensed as incurred. Purchase price allocations may be preliminary and, during the measurement period not to exceed one year from the date of acquisition, changes in assumptions and estimates that result in adjustments to the fair value of assets acquired and liabilities assumed are recorded in the period the adjustments are determined. For business combinations achieved in stages, the Company’s previously held interest in the acquiree is remeasured at its acquisition date fair value, with the resulting gain or loss recorded in the Statements of (Loss) Income. For a pre-existing relationship between the Company and the acquiree, that is not extinguished on the business combination, such a relationship is considered effectively settled as part of the business combination even if it is not legally cancelled. At the acquisition date, it becomes an intercompany relationship and is eliminated upon consolidation.
Goodwill	Goodwill Goodwill represents the excess of the purchase price over the estimated fair value of the net assets acquired in a business acquisition. Goodwill is allocated to reporting units and tested for impairment annually as of December 31 each year and when events or changes in circumstances indicate that the carrying value of a reporting unit exceeds its fair value. The Company generally elects to utilize the optional qualitative assessment for goodwill to determine whether it is more likely than not that the carrying value of a reporting unit is higher than its fair value. If it is determined that the fair value is more likely than not to be lower than the carrying value, a quantitative goodwill impairment test is performed by determining the fair value of the reporting unit. The fair value of a reporting unit is determined using either the income approach utilizing estimates of discounted future cash flows or the market approach utilizing recent transaction activity for comparable properties. These approaches are considered level 3 fair value measurements. If the carrying amount of the reporting unit exceeds its fair value, an impairment loss is recognized in an amount equal to that excess, limited to the total amount of goodwill allocated to that reporting unit.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment is initially recorded at cost. Depreciation of plant and equipment is determined on the straight-line method over the following useful lives of the assets: Classification Estimated Useful Lives Leasehold and land improvements 5 - 20 years Buildings 4 - 30 years Machinery and equipment 3 - 30 years
Impairments of Long-Lived Assets	Impairments of Long-Lived Assets Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Long-lived assets are grouped with other assets to the lowest level to which identifiable cash flows are largely independent of the cash flows of other groups of assets and liabilities. Management assesses the recoverability of the carrying cost of the assets based on a review of projected undiscounted cash flows. If an asset is held for sale, management reviews its estimated fair value less cost to sell. Fair value is determined using pertinent market information, including appraisals or broker’s estimates, and/or projected discounted cash flows. In the event an impairment loss is identified, it is recognized based on the amount by which the carrying value exceeds the estimated fair value of the long-lived asset.
Segment Reporting	Segment Reporting Operating segments are reported in a manner consistent with internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (“CEO”). The Company has identified four operating segments – Produce, Cannabis-Canada, Cannabis-U.S. and Energy.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs based on quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets and liabilities in active markets, or quoted prices for identical assets and liabilities in markets that are not active. Level 3: Unobservable inputs that reflect our own assumptions.
Share-Based Compensation	Share-Based Compensation The Company grants stock options and performance-based restricted stock (“RS”) to certain employees and directors. Compensation costs for awards of stock-based compensation settled in shares are determined based on the fair value of the share-based instrument at the time of grant and are recognized as expense over the vesting period of the share-based instrument. The Company recognizes forfeitures as they occur. Stock options generally vest over three years ( 33 % per year following the grant date) and expire after ten years . Each tranche in an award is considered a separate award with its own vesting period. The fair value of each tranche is measured at the date of grant using the Black-Scholes option pricing model. Compensation expense is recognized over the tranche’s vesting period by increasing additional paid-in capital based on the number of awards expected to vest. The number of awards expected to vest is reviewed at least annually, with any impact recognized immediately. RS grants will be settled using the Company’s own equity and issued from treasury if the performance standard is met. The equity-settled share-based compensation is measured at the fair value of the Company’s Common Shares as at the grant date in accordance with the terms of the Company’s Stock Compensation Plan. The fair value determined at the grant date is charged to income when performance-based vesting conditions are met, based on the number of RS that will eventually be converted to Common Shares, with a corresponding increase in equity.
Advertising	Advertising Advertising costs are presented within selling, general and administrative costs in the Consolidated Statements of Operations. The Company supports its products with advertising to build brand awareness of the Company’s various products in addition to other marketing programs executed by the Company’s marketing teams. Advertising costs for the years ended December 31, 2022 and 2021 were $ 6,122 and $ 3,473 , respectively.
New Accounting Pronouncements	New Accounting Pronouncements In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”) . ASU 2020-04 provides optional expedients and exceptions for applying GAAP to debt instruments, derivatives, and other contracts that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform. This guidance is optional and may be elected through December 31, 2022 using a prospective application on all eligible contract modifications. The Company has a line of credit that incorporates LIBOR as a referenced interest rate. It is difficult to predict what effect, if any, the phase-out of LIBOR and the use of alternative benchmarks may have on the Company’s business or on the overall financial markets. The Company has not adopted any of the optional expedients or exceptions through December 31, 2022 but will continue to evaluate the possible adoption of any such expedients or exceptions.

Summary Of Significant Accoun_3

Summary Of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Estimated Useful Lives of Intangible Assets	Classification Estimated Useful Lives Licenses 5 - 22 years Brand and trademarks Indefinite Customer relationships 10 years Computer software 3 - 5 years
Schedule of Tangible Assets Useful Life	Property, plant and equipment is initially recorded at cost. Depreciation of plant and equipment is determined on the straight-line method over the following useful lives of the assets: Classification Estimated Useful Lives Leasehold and land improvements 5 - 20 years Buildings 4 - 30 years Machinery and equipment 3 - 30 years

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventories consisted of the following: Classification December 31, 2022 December 31, 2021 Cannabis: Raw materials $ 1,089 $ 2,071 Work-in-process 10,872 5,056 Finished goods 36,094 32,161 Packaging 6,909 5,877 Produce and Energy: Crop inventory 14,886 19,475 Purchased produce inventory 599 2,485 Spare parts inventory and packaging 133 1,552 Inventory $ 70,582 $ 68,677

Property Plant And Equipment (T

Property Plant And Equipment (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Property, plant and equipment consisted of the following: Classification December 31, 2022 December 31, 2021 Land $ 13,411 $ 14,095 Leasehold and land improvements 5,372 5,224 Buildings 214,146 184,444 Machinery and equipment 82,396 79,070 Construction in progress 10,033 39,206 Less: Accumulated depreciation ( 117,657 ) ( 106,335 ) Property, plant and equipment, net $ 207,701 $ 215,704

Pure Sunfarms Acquisitions (Tab

Pure Sunfarms Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2022
Summary of company share of the joint venture	For the period January 1, 2020 to November 1, 2020, the Company's share of the joint venture consisted of the following: Balance, January 1, 2020 $ 41,334 Investments in joint venture 16,393 Share of net income for the year 4,980 Balance, November 1, 2020 $ 62,707
Pure Sunfarms [Member]
Business Acquisitions Purchase Price Allocation To Assets Acquired And Liabilities Assumed	The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 45,259 Promissory note 15,011 Shareholder loan 4,529 Promissory note owed to PSF from Emerald 439 Due to related party 61 Fair value of previously held investment shares held by Village Farms 52,569,197 $ 1.767 92,881 Total fair value of consideration $ 158,180 November 2, 2020 ASSETS Cash and cash equivalents $ 10,860 Trade receivables, net 10,553 Inventories 32,393 Prepaid expenses and deposits 3,572 Property, plant and equipment 122,831 Goodwill 23,095 Intangibles 16,670 Total assets 219,974 LIABILITIES Trade payables $ 3,849 Accrued liabilities 13,062 Income taxes payable 2,173 Current maturities of long-term debt 2,306 Deferred revenue 77 Long-term debt 23,903 Deferred tax liabilities 16,424 Total liabilities 61,794 Net assets acquired 158,180

BHB Acquisitions (Tables)

BHB Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2022
Balanced Health Botanicals [Member]
Business Acquisition [Line Items]
Business Acquisitions Purchase Price Allocation To Assets Acquired And Liabilities Assumed	The following table shows the allocation of the purchase price to assets acquired and liabilities assumed, based on estimates of fair value, including a summary of the identifiable classes of consideration transferred, and amounts by category of assets acquired and liabilities assumed at the acquisition date: Consideration paid Shares Share Price Amount Cash $ 30,000 Village Farms common shares issued 4,707,113 $ 8.87 41,752 Working capital adjustment ( 2 ) Total fair value of consideration $ 71,750 August 16, 2021 ASSETS Cash and cash equivalents $ 4,056 Trade and other receivables, net 1,030 Inventories 1,796 Prepaid expenses and deposits 667 Property, plant and equipment 1,900 Right-of-use asset 5,099 Goodwill 60,008 Intangibles 9,394 Other assets 362 Total assets 84,312 LIABILITIES Trade payables 688 Accrued liabilities 6,659 Other current liabilities 192 Lease liability 5,023 Total liabilities 12,562 Net assets acquired 71,750

Rose Acquisition (Tables)

Rose Acquisition (Tables)	12 Months Ended
	Dec. 31, 2022
Rose Acquisition [Member]
Business Acquisition [Line Items]
Business Acquisitions Purchase Price Allocation To Assets Acquired And Liabilities Assumed	Consideration paid Shares Share Price Amount Cash $ 15,859 Village Farms common shares issued 2,411,280 $ 9.04 21,798 Working capital adjustment $ 1,055 Total fair value of consideration $ 38,712 November 15, 2021 ASSETS Cash and cash equivalents $ 1,118 Trade and other receivables, net 1,595 Inventories 3,586 Prepaid expenses and deposits 498 Property, plant and equipment 16,423 Goodwill 24,133 Intangible assets 14,170 Total assets 61,523 LIABILITIES Trade payables 774 Accrued liabilities 1,803 Deferred tax liability 3,755 Total liabilities 6,332 Mezzanine equity 16,479 Total liabilities and mezzanine equity 22,811 Net assets acquired $ 38,712

Goodwill and Intangibles Asset

Goodwill and Intangibles Asset (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Carrying Value of Goodwill by Reportable Segment	The following table presents the changes in the carrying value of goodwill by reportable segment: Cannabis - Canada Cannabis - United States Total Balance as of December 31, 2021 $ 57,525 $ 60,008 $ 117,533 Purchase price adjustment 3,755 — 3,755 Reclassification to intangible assets ( 14,170 ) — ( 14,170 ) Foreign currency translation adjustment ( 2,224 ) — ( 2,224 ) Impairments — ( 38,669 ) ( 38,669 ) Balance as of December 31, 2022 $ 44,886 $ 21,339 $ 66,225
Schedule of Acquired Intangible Assets	Intangibles consisted of the following: Classification December 31, 2022 December 31, 2021 Licenses $ 17,691 $ 12,835 Brand and trademarks* 12,719 12,951 Customer relationships 13,291 — Computer software 1,955 2,014 Other* 144 144 Less: Accumulated amortization ( 4,013 ) ( 1,550 ) Less: Impairments ( 4,630 ) — Intangibles, net $ 37,157 $ 26,394 *Indefinite-lived intangible assets.
Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets	The expected future amortization expense for definite-lived intangible assets as of December 31, 2022 is as follows: Fiscal period 2023 $ 3,320 2024 3,186 2025 3,100 2026 3,012 2027 3,012 Thereafter 13,294 Intangibles, net $ 28,924

Line of Credit and Long-term _2

Line of Credit and Long-term Debt (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Schedule of Debt	Balance outstanding as of December 31, 2022 2021 Term Loan - ("FCC Loan") - repayable by monthly principle of payments of $ 164 and accrued interest at a rate of 7.71 %; matures April 1, 2025 $ 24,755 $ 26,723 Term Loan - VFCE: CA$ 3.0 M - non-revolving fixed rate loan with fixed interest rate of 4.98 %; matures June 2023 — 491 Term Loan - Pure Sunfarms - CA$ 19.0 M - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount, interest rate of 8.7 %; matures February 2024 9,664 11,870 Term loan - Pure Sunfarms - CA$ 25.0 - Canadian prime interest rate plus an applicable margin, repayable in quarterly payments equal to 2.50 % of the outstanding principal amount starting June 30, 2021 , interest rate of 8.7 %; matures February 2024 14,867 17,806 BDC Facility - Pure Sunfarms - non-revolving demand loan at prime interest plus 3.75 %, matures December 31, 2031 4,181 4,946 Total $ 53,467 $ 61,836
Schedule of maturities of long term debt	The aggregate annual principal maturities of long-term debt for the next five years and thereafter are as follows: 2023 $ 8,309 2024 25,035 2025 23,190 2026 718 2027 671 Thereafter 2,213 $ 60,136

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Schedule of accrued liabilities	December 31, 2022 December 31, 2021 Received not invoiced $ 6,252 $ 3,470 Accrued payroll 2,766 3,552 Accrued grower partner payables 824 2,248 Other 3,222 4,898 $ 13,064 $ 14,168

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Summary of lease related expenses	The components of lease related expenses are as follows: Year ended December 31, 2022 2021 Operating lease expense (a) $ 4,434 $ 2,926 Finance lease expense: Amortization of right-of-use assets — 25 Total finance lease expense $ — $ 25 (a) Includes short-term lease costs of $ 999 and $ 680 for the year ended December 31, 2022 and 2021 .
Schedule includes other information about leases	Cash paid for amounts included in the measurement of lease liabilities: Year ended December 31, 2022 2021 Operating cash flows from operating leases and finance leases $ 604 $ 1,351 Financing cash flows from finance leases $ — $ 17 December 31, 2022 Weighted average remaining lease term: Operating leases 5.50 Weighted average discount rate: Operating leases 7.47 %
Summary of maturities of lease liabilities	Maturities of lease liabilities are as follows: Operating leases 2023 $ 2,616 2024 2,126 2025 1,911 2026 1,958 2027 1,350 Thereafter 2,168 Undiscounted lease cash flow commitments 12,129 Reconciling impact from discounting ( 2,374 ) Lease liabilities on consolidated statement of financial position as of December 31, 2022 $ 9,755

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Summary of Income Tax Provision (Recovery)	The components of the provision for (recovery of) income tax for the years ended December 31, 2022, 2021 and 2020 are as follows: 2022 Current Deferred Total US Federal $ — $ 14,650 $ 14,650 US State 72 ( 2,085 ) ( 2,013 ) Canadian ( 5,222 ) ( 2,734 ) ( 7,956 ) $ ( 5,150 ) $ 9,831 $ 4,681 2021 Current Deferred Total US Federal $ — $ ( 3,278 ) $ ( 3,278 ) US State 135 ( 176 ) ( 41 ) Canadian ( 795 ) 588 ( 207 ) $ ( 660 ) $ ( 2,866 ) $ ( 3,526 ) 2020 Current Deferred Total US Federal $ — $ ( 4,879 ) $ ( 4,879 ) US State 260 ( 434 ) ( 174 ) Canadian 3,412 ( 1,149 ) 2,263 $ 3,672 $ ( 6,462 ) $ ( 2,790 )
Summary of Effective Income Tax Rate Reconciliation	The (recovery of) provision for income taxes reflected in the consolidated statements of (loss) income for the years ended December 31, 2022, 2021 and 2020 differs from the amounts computed at the federal statutory tax rates. The principal differences between the statutory income tax (recovery) and the effective provision for (recovery of) income taxes are summarized as follows: Year Ended December 31, 2022 2021 2020 (Loss) income before income taxes $ ( 96,734 ) $ ( 12,651 ) $ 8,818 Tax (recovery) calculated at US domestic tax rates ( 20,339 ) ( 2,592 ) 1,869 State tax adjustments ( 1,799 ) ( 230 ) ( 310 ) Non-deductible items 928 1,516 ( 6,531 ) True up of prior year income tax estimates — ( 648 ) ( 181 ) Share of income from joint venture — — ( 228 ) Deferred adjustment ( 3,324 ) ( 2,429 ) 343 Tax rate differences on deferred items 308 397 49 Foreign rate differentials 88 86 1,643 Change in tax rates 5 5 37 Change in valuation allowance 28,684 57 3 Other 130 312 516 Recovery of income taxes $ 4,681 $ ( 3,526 ) $ ( 2,790 )
Summary of Deferred Tax Assets and Liabilities	Significant components of the Company’s net deferred income taxes at December 31, 2022 and 2021 are as follows: 2022 2021 Deferred tax assets: Other assets $ 5,536 $ 5,140 Long-term debt 943 832 Tax losses: Non-capital and farm losses 33,579 22,860 Provisions: Debt and unit issuance costs 1,683 2,194 Tax losses: Valuation allowance ( 30,419 ) ( 1,708 ) 11,322 29,318 Deferred tax liabilities: Joint venture shares ( 2,406 ) ( 2,662 ) Cash adjustment ( 12,861 ) ( 11,514 ) Property, plant and equipment ( 11,610 ) ( 17,033 ) ( 26,877 ) ( 31,209 ) Net tax assets $ ( 15,555 ) $ ( 1,891 )

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Summary of Net Sales by the Countries and Property, Plant and Equipment, Net of Accumulated Depreciation	The Company’s primary operations are in the United States and Canada. Segment information as of and for the years ended December 31, 2022, 2021 and 2020: 2022 2021 2020 Sales Produce $ 160,252 $ 159,778 $ 156,891 Cannabis – Canada 109,882 96,434 12,778 Cannabis – United States 23,302 11,345 — Energy 136 463 417 $ 293,572 $ 268,020 $ 170,086 Interest expense Produce $ 1,472 $ 561 $ 1,759 Cannabis – Canada 1,768 2,236 243 Cannabis – United States — 1 — Energy 4 37 54 $ 3,244 $ 2,835 $ 2,056 Interest income Corporate $ 196 $ 117 $ 623 Cannabis – Canada 11 9 2 $ 207 $ 126 $ 625 Depreciation and amortization Produce $ 5,044 $ 5,238 $ 5,356 Cannabis – Canada 7,445 5,875 822 Cannabis – United States 565 299 — Energy — 1,297 647 $ 13,054 $ 12,709 $ 6,825 Gross margin Produce $ ( 17,382 ) $ 1,474 $ 9,621 Cannabis – Canada 29,388 37,209 2,193 Cannabis – United States 15,659 7,947 — Energy ( 168 ) ( 1,451 ) ( 854 ) $ 27,497 $ 45,179 $ 10,960 Total assets 2022 2021 United States $ 113,497 $ 116,654 Canada 346,126 450,257 Netherlands 5,662 — $ 465,285 $ 566,911 Property, plant and equipment, net 2022 2021 United States $ 37,780 $ 39,583 Canada 169,921 176,121 $ 207,701 $ 215,704

(Loss) Income Per Share (Tables

(Loss) Income Per Share (Tables)	12 Months Ended
	Dec. 31, 2022
Income Per Share [Abstract]
Summary of Basic and Diluted Net Income (Loss) per Ordinary Share	Basic net (loss) income per share is computed using the weighted average number of Common Shares outstanding for the period. Basic and diluted net income per ordinary share is calculated as follows: For the Years Ended December 31, (shares in thousands) 2022 2021 2020 Numerator: Net (loss) income including non-controlling interests $ ( 101,415 ) $ ( 9,125 ) $ 11,608 Less: Net loss attributable to non-controlling interests $ 269 $ 46 $ — Net (loss) income attributable to Village Farms International, Inc. shareholders $ ( 101,146 ) $ ( 9,079 ) $ 11,608 Denominator: Weighted average number of common shares – basic 89,127 82,161 58,526 Effect of dilutive securities – share-based employee options and awards — — 2,964 Weighted average number of common shares – diluted 89,127 82,161 61,490 Anti-dilutive options and awards (1) 4,089 3,822 500 Net (loss) income per ordinary share: Basic $ ( 1.13 ) $ ( 0.11 ) $ 0.20 Diluted $ ( 1.13 ) $ ( 0.11 ) $ 0.19 (1) Options to purchase shares of common stock and unvested RSUs are not included in the calculation of net (loss) income per share because the effect would have been anti-dilutive.

Shareholders' Equity and Shar_2

Shareholders' Equity and Share Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Summary of Fair Value of Stock Option Valuation Assumptions	The following key assumptions were used in the valuation model to value stock option grants for each respective period: 2022 2021 2020 Expected volatility 84.0 % - 89.9 % 68.3 % - 75.7 % 71.1 % Dividend $nil $nil $nil Risk-free interest rate 1.41 % - 3.28 % 1.07 % - 1.54 % 0.52 % Expected life 6.5 years 4.5 years - 6.9 years 7.1 years Fair value $ 0.93 - $ 4.33 $ 4.29 - $ 7.31 $ 4.65
Summary of Stock Based Compensation Stock Option	Stock option transactions under the Company’s plan for the years ended December 31, 2022, 2021 and 2020 are summarized as follows: Number of Weighted Weighted Aggregate Outstanding at January 1, 2020 2,452,666 $ 3.93 5.60 $ 8,784 Granted during 2020 1,081,488 $ 6.54 9.75 $ 254 Exercised during 2020 ( 425,166 ) $ 1.01 1.62 $ 2,039 Forfeited/expired during 2020 ( 41,666 ) $ 5.17 Outstanding at December 31, 2020 3,067,322 $ 5.42 6.82 $ 15,735 Exercisable at December 31, 2020 1,618,168 $ 3.07 4.58 $ 11,865 Granted during 2021 792,236 $ 8.47 9.78 $ 57 Exercised during 2021 ( 177,000 ) $ 1.07 1.14 $ 1,813 Forfeited during 2021 ( 60,000 ) $ 10.70 Outstanding at December 31, 2021 3,622,558 $ 6.20 7.89 $ 6,530 Exercisable at December 31, 2021 2,042,663 $ 4.80 5.14 $ 6,001 Granted during 2022 725,360 $ 2.74 9.70 $ 16 Exercised during 2022 ( 180,000 ) $ 1.30 0.51 $ 772 Forfeited during 2022 ( 78,500 ) $ 8.45 Outstanding at December 31, 2022 4,089,418 $ 5.76 6.77 $ 152 Exercisable at December 31, 2022 2,549,401 $ 5.88 5.46 $ 133
Schedule of Nonvested Stock Options Activity	A summary of the status of the Company’s non-vested stock options, and the changes during the year ended December 31, 2022 is presented below: Number of Weighted Aggregate Non-vested at January 1, 2022 1,579,895 $ 5.28 Granted 725,360 $ 2.06 Vested ( 696,238 ) $ 5.35 Forfeited ( 69,000 ) $ 5.75 Non-vested at December 31, 2022 1,540,017 $ 3.72 $ 19
Summary of Performance Base Restricted Share Unit	Performance-based restricted share unit activity for the years ended December 31, 2022, 2021 and 2020 is as follows: Number of Weighted Average Outstanding at January 1, 2020 739,000 $ 6.08 Granted 1,068,000 $ 4.75 Issued ( 840,000 ) $ 4.83 Forfeited/expired ( 98,000 ) $ 7.16 Outstanding at December 31, 2020 869,000 $ 5.89 Exercisable at December 31, 2020 75,000 $ 4.79 Granted 158,000 $ 7.72 Exercised ( 487,000 ) $ 5.70 Forfeited ( 310,000 ) $ 6.66 Outstanding at December 31, 2021 230,000 $ 6.83 Exercisable at December 31, 2021 200,000 $ 6.49 Granted — — Exercised ( 200,000 ) $ 6.41 Forfeited/expired — — Outstanding at December 31, 2022 30,000 $ 8.31 Exercisable at December 31, 2022 30,000 $ 8.31
Summary of Non-Vested Performance-Based Restricted Share Units	A summary of the status of the Company’s non-vested performance-based restricted share units, and the changes during the year ended December 31, 2022, is presented below: Number of Weighted Average Non-vested at January 1, 2022 30,000 $ 8.24 Vested ( 30,000 ) $ 8.31 Non-vested at December 31, 2022 — —

Changes in Non-Cash Working C_2

Changes in Non-Cash Working Capital Items (Tables)	12 Months Ended
	Dec. 31, 2022
Disclosure Of Changes In Non Cash Working Capital Items [Abstract]
Summary of Changes in Non Cash Working Capital Items	For the Years Ended December 31, 2022 2021 2020 Trade receivables $ 3,310 $ ( 9,914 ) $ ( 3,196 ) Inventories ( 14,583 ) ( 16,761 ) 2,997 Note receivable — — 765 Due from joint ventures — 4 4,363 Other receivables ( 4 ) ( 399 ) 199 Prepaid expenses and deposits 3,815 ( 3,201 ) ( 1,245 ) Trade payables 6,697 6,327 ( 1,665 ) Accrued liabilities 7,805 ( 10,389 ) 6,565 Other assets, net of other liabilities ( 9,286 ) ( 12,816 ) 4,289 $ ( 2,246 ) $ ( 47,149 ) $ 13,072

Description Of Business - Addit

Description Of Business - Additional Information (Detail)	Dec. 31, 2022
Rose LifeScience Inc. [Member]
Nature Of Operations [Line Items]
Equity ownership percentage	70%
Leli Holland B.V. [Member]
Nature Of Operations [Line Items]
Equity ownership percentage	85%

Summary Of Significant Accoun_4

Summary Of Significant Accounting Policies - Estimated useful Lives of Intangible Assets (Detail)	12 Months Ended
	Dec. 31, 2022
Licenses [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	5 years
Licenses [Member] | Maximum [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	22 years
Brand and Trademarks [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	Indefinite
Customer Relationships [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	10 years
Computer Software [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	3 years
Computer Software [Member] | Maximum [Member]
Significant Accounting Policies [Line Items]
Estimated Useful Life	5 years

Summary Of Significant Accoun_5

Summary Of Significant Accounting Policies - Summary of Estimated Useful Lives of Property Plant and Equipment (Detail)	12 Months Ended
	Dec. 31, 2022
Leaseholds and Leasehold Improvements [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	5 years
Leaseholds and Leasehold Improvements [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	20 years
Buildings [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	4 years
Buildings [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	30 years
Machinery and Equipment [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	3 years
Machinery and Equipment [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Estimated Useful Life	30 years

Summary Of Significant Accoun_6

Summary Of Significant Accounting Policies - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) Segment	Dec. 31, 2021 USD ($)
Significant Accounting Policies [Line Items]
Number of reportable segments | Segment	4
Stock options vesting period	3 years	3 years
Stock options period of expiry	10 years
Advertising cost | $	$ 6,122	$ 3,473
Share-based Payment Arrangement, Tranche One [Member]
Significant Accounting Policies [Line Items]
Stock options vesting percentage	33%
Share-based Payment Arrangement, Tranche Two [Member]
Significant Accounting Policies [Line Items]
Stock options vesting percentage	33%
Share-based Payment Arrangement, Tranche Three [Member]
Significant Accounting Policies [Line Items]
Stock options vesting percentage	33%

Inventories - Summary of Invent

Inventories - Summary of Inventory Current (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Inventory [Line Items]
Inventories	$ 70,582	$ 68,677
Raw Materials | Cannabis Business [Member]
Inventory [Line Items]
Inventories	1,089	2,071
Work-In-Process | Cannabis Business [Member]
Inventory [Line Items]
Inventories	10,872	5,056
Finished Goods | Cannabis Business [Member]
Inventory [Line Items]
Inventories	36,094	32,161
Packaging | Cannabis Business [Member]
Inventory [Line Items]
Inventories	6,909	5,877
Crop Inventory | Produce And Energy
Inventory [Line Items]
Inventories	14,886	19,475
Purchased Produce | Produce And Energy
Inventory [Line Items]
Inventories	599	2,485
Spare Parts Inventory And Packaging | Produce And Energy
Inventory [Line Items]
Inventories	$ 133	$ 1,552

Inventories - Additional inform

Inventories - Additional information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Crop Inventory
Inventory [Line Items]
Impairment loss on inventory	$ 11,038,000	$ 0	$ 0

Property Plant And Equipment -

Property Plant And Equipment - Summary of Property, Plant and Equipment (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Property Plant And Equipment [Line Items]
Less: Accumulated depreciation	$ (117,657)	$ (106,335)
Property, plant and equipment, net	207,701	215,704
Land [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	13,411	14,095
Leaseholds and Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	5,372	5,224
Buildings [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	214,146	184,444
Machinery and Equipment [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	82,396	79,070
Construction in Progress [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 10,033	$ 39,206

Property Plant And Equipment _2

Property Plant And Equipment - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation on property,plant and equipment	$ 10,795	$ 12,709	$ 6,825

Business Combinations - Pure Su

Business Combinations - Pure Sunfarms Acquisition (Additional Information) (Details) $ in Thousands, $ in Thousands			3 Months Ended	9 Months Ended	12 Months Ended
	Nov. 02, 2020 CAD ($) shares	Nov. 02, 2020 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2020 USD ($)	Dec. 31, 2022 USD ($)	Nov. 02, 2020 USD ($) shares	Mar. 02, 2020 CAD ($)	Mar. 02, 2020 USD ($)
Business Acquisition [Line Items]
Goodwill					$ 3,755
Pure Sunfarms [Member]
Business Acquisition [Line Items]
Promissory notes payable						$ 15,011
Goodwill		$ 22,596
Gain on revaluation of previously held investment		$ 23,600
Additional equity transferred percent							2.50%	2.50%
Additional equity interest received fair value								$ 4,700
Pure Sunfarms [Member] | Canada, Dollars [Member]
Business Acquisition [Line Items]
Goodwill	$ 30,618
Additional equity interest received fair value							$ 6,500
Emerald Health [Member] | Pure Sunfarms [Member]
Business Acquisition [Line Items]
Business acquisition, date of acquisition agreement	Nov. 02, 2020	Nov. 02, 2020
Business acquisition, name of acquired entity	Emerald Health Therapeutics Inc. (“Emerald”)	Emerald Health Therapeutics Inc. (“Emerald”)
Business acquisition, percentage of voting interests acquired	100%					100%
Business combination, consideration transferred, total		$ 60,000
Payments to acquire businesses		$ 45,000
Promissory notes payable						$ 15,000
Emerald Health [Member] | Pure Sunfarms [Member] | Joint Venture [Member]
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired	58.70%					58.70%
Equity (losses) earnings from unconsolidated entities			$ 1,443	$ 5,437
Emerald Health [Member] | Pure Sunfarms [Member] | Canada, Dollars [Member]
Business Acquisition [Line Items]
Business combination, consideration transferred, total	$ 79,900
Payments to acquire businesses	60,000
Promissory notes payable	$ 19,900
Emerald Health [Member] | Pure Sunfarms [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Number of shares acquired | shares	36,958,500					36,958,500

Business Combinations - Summary

Business Combinations - Summary of Assets and Liabilities (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Nov. 02, 2020
ASSETS
Goodwill	$ 66,225	$ 117,533
Pure Sunfarms [Member]
Business Acquisition [Line Items]
Cash			$ 45,259
Promissory note			15,011
Shareholder loan			4,529
Promissory note owed to PSF from Emerald			439
Due to related party			61
Total fair value of consideration			158,180
ASSETS
Cash and cash equivalents			10,860
Trade receivables, net			10,553
Inventories			32,393
Prepaid expenses and deposits			3,572
Property, plant and equipment			122,831
Goodwill			23,095
Intangibles			16,670
Total assets			219,974
LIABILITIES
Trade payables			3,849
Accrued liabilities			13,062
Income taxes payable			2,173
Current maturities of long-term debt			2,306
Deferred revenue			77
Long-term debt			23,903
Deferred tax liabilities			16,424
Total liabilities			61,794
Net assets acquired			$ 158,180
Pure Sunfarms [Member] | Village Farm [Member]
Business Acquisition [Line Items]
Fair value of previously held investment shares held by Village Farms, shares			52,569,197
Business acquisition, share price			$ 1.767
Fair value of previously held investment shares held by Village Farms			$ 92,881

Business Combinations - Summa_2

Business Combinations - Summary of company share of the joint venture (Details) - Pure Sunfarms [Member] $ in Thousands	10 Months Ended
	Nov. 01, 2020 USD ($)
Business Acquisition [Line Items]
Balance, January 1, 2020	$ 41,334
Investments in joint venture	16,393
Share of net income for the year	4,980
Balance, November 1, 2020	$ 62,707

Business Combinations - BHB Acq

Business Combinations - BHB Acquisitions - Additional Information (Details) - USD ($) $ in Thousands	Aug. 16, 2021	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill		$ 66,225	$ 117,533
Balanced Health Botanicals
Business Acquisition [Line Items]
Business acquisition, date of acquisition agreement	Aug. 16, 2021
Business acquisition, percentage of voting interests acquired	100%
Payments to acquire businesses	$ 30,000
Business acquisition, purchase price consideration number of shares issued	4,707,113
Business combination, consideration transferred, total	$ 42,000
Percentage of common shares cease to be restricted shares on closing date	0.25%
Percentage of common shares cease to be restricted shares on last day of 4 month period	0.25%
Percentage of common stock cease to be restricted shares on last day of 8 month period	0.25%
Percentage of common stock cease to be restricted shares on last day of 12 month period	0.25%
Goodwill	$ 60,008
Brand intangible	$ 9,250
Balanced Health Botanicals | Common Stock [Member]
Business Acquisition [Line Items]
Business acquisition, purchase price consideration number of shares issued	4,707,113

Business Combinations - BHB A_2

Business Combinations - BHB Acquisition - Summary of Assets and Liabilities (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Aug. 16, 2021
ASSETS
Goodwill	$ 66,225	$ 117,533
Balanced Health Botanicals
Business Acquisition [Line Items]
Cash			$ 30,000
Village Farms common shares issued			4,707,113
Business acquisition, share price			$ 8.87
Village Farms common shares issued			$ 41,752
Working capital adjustment			(2)
Total fair value of consideration			71,750
ASSETS
Cash and cash equivalents			4,056
Trade and other receivables, net			1,030
Inventories			1,796
Prepaid expenses and deposits			667
Property, plant and equipment			1,900
Right-of-use asset			5,099
Goodwill			60,008
Intangible asset			9,394
Other assets			362
Total assets			84,312
LIABILITIES
Trade payables			688
Accrued liabilities			6,659
Other current liabilities			192
Lease liability			5,023
Total liabilities			12,562
Net assets acquired			$ 71,750

Business Combinations - Rose Ac

Business Combinations - Rose Acquisition - Additional Information (Details) $ in Thousands, $ in Thousands		12 Months Ended
	Nov. 15, 2021 CAD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2022 CAD ($)	Nov. 15, 2021 USD ($) Cofounder shares
Business Acquisition [Line Items]
Goodwill		$ 66,225	$ 117,533
Amortization of intangible assets		$ 2,259	$ 916	$ 122
Rose Acquisition [Member]
Business Acquisition [Line Items]
Business acquisition, date of acquisition agreement	Nov. 15, 2021
Business acquisition, percentage of voting interests acquired							70%
Business combination, consideration transferred, total	$ 46,700
Payments to acquire businesses	$ 19,900
Business acquisition, purchase price consideration number of shares issued | shares							2,411,280
Percentage of common shares cease to be restricted shares 4 months following closing date	33%
Percentage of common shares cease to be restricted shares 8 months after closing date	33%
Number of management shareholders | Cofounder							2
Goodwill					$ 24,133	$ 30,673	$ 24,133
Intangibles					$ 14,170	$ 18,010	14,170
Asset acquisition, intangible assets amortized period		10 years
Amortization of intangible assets		$ 1,500
Redeemable non controlling interest classified as temporary mezzanine equity.							$ 16,479
Rose Acquisition [Member] | Management Shareholders [Member]
Business Acquisition [Line Items]
Percentage of non-voting retained interest							30%
Rose Acquisition [Member] | Call Option [Member]
Business Acquisition [Line Items]
Retained interest percentage to be acquired upon occurrence of liquidity events							34%
Rose Acquisition [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Business acquisition, purchase price consideration number of shares issued | shares							2,411,280

Business Combinations - Rose _2

Business Combinations - Rose Acquisition - Summary of Assets and Liabilities (Details) $ / shares in Units, $ in Thousands, $ in Thousands	Dec. 31, 2022 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2022 CAD ($)	Dec. 31, 2021 USD ($)	Nov. 15, 2021 USD ($) $ / shares shares
ASSETS
Goodwill	$ 66,225			$ 117,533
Rose Acquisition [Member]
Business Acquisition [Line Items]
Cash					$ 15,859
Village Farms common shares issued | shares					2,411,280
Business acquisition, share price | $ / shares					$ 9.04
Village Farms common shares issued					$ 21,798
Working capital adjustment					1,055
Total fair value of consideration					38,712
ASSETS
Cash and cash equivalents					1,118
Trade and other receivables, net					1,595
Inventories					3,586
Prepaid expenses and deposits					498
Property, plant and equipment					16,423
Goodwill		$ 24,133	$ 30,673		24,133
Intangible asset		$ 14,170	$ 18,010		14,170
Total assets					61,523
LIABILITIES
Trade payables					774
Accrued liabilities					1,803
Deferred tax liability					3,755
Total liabilities					6,332
Mezzanine equity					16,479
Total liabilities and mezzanine equity					22,811
Net assets acquired					$ 38,712

Asset Acquisition - Additional

Asset Acquisition - Additional Information (Detail)		1 Months Ended
	Jul. 19, 2022 USD ($)	Sep. 30, 2021 EUR (€)
Leli Holland B V [Member] | Option Agreement [Member]
Asset Acquisition [Line Items]
Right to acquire ownership interest percentage		80%
Payment to acquire ownership interest | €		€ 50,000
Transaction value to acquire interest | €		3,950,000
Due and payable to shareholders | €		€ 950,000
Leli Holland B.V. [Member]
Asset Acquisition [Line Items]
Asset acquisition, percentage acquired	80%
Asset acquisition, additional percentage acquired	5%
Asset acquisition, total cash consideration | $	$ 4,693
Asset acquisition, intangible assets amortized period	5 years
Asset Acquisition, other assets acquired | $	$ 0
Asset acquisition, other liabilities acquired | $	$ 0

Investments - Additional Inform

Investments - Additional Information (Detail) $ in Thousands, $ in Millions		1 Months Ended	12 Months Ended
	Feb. 10, 2022 USD ($)	Sep. 30, 2021 EUR (€)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Feb. 10, 2022 AUD ($)
Net income (loss)			$ (101,146)	$ (9,079)	$ 11,608
Leli Holland B V [Member] | Option Agreement [Member]
Right to acquire ownership interest percentage		80%
Payment to acquire ownership interest | €		€ 50,000
Transaction value to acquire interest | €		3,950,000
Due and payable to shareholders | €		€ 950,000
Convertible Promissory Note [Member] | Atom [Member]
Convertible promissory note	$ 719					$ 1
Notes interest rate	12%					12%
Notes maturity date	Aug. 10, 2023
Balance of note including accrued interest	$ 791
V F Hemp [Member]
Net assets			0	(10,369)
Net income (loss)			2,668	$ 474
Share of losses from joint venture			2,284
Inventory write-off from joint venture			$ 592

Goodwill and Intangibles Asse_2

Goodwill and Intangibles Assets - Additional Information (Detail) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Line Items]
Goodwill		$ (38,669,000)
Intangible assets		4,630,000
Amortization of intangible assets		2,259,000	$ 916,000	$ 122,000
Cannabis Canada [Member]
Goodwill [Line Items]
Goodwill		0
Intangible assets		0
Recovered amount undiscounted cash flows exceeded carrying value of definite lived intangibles		$ 24,969,000
Recoverable amount covering period		3 years
Recovered amount higher (lower) than carrying amount of goodwill		$ 17,196,000
Amount of higher (lower) in carrying value of recovered amount of brand		1,033,000
Recovered amount higher (lower) than carrying amount of brand		3,420,000
Impairment to definite lived intangibles		$ 0
Cannabis Canada [Member] | Increase of 1% to Discount Rate [Member]
Goodwill [Line Items]
Increase in post-tax discount rate		0.50%
Additional increase in post tax discount rate		1%
Increase in impairment to goodwill		$ 29,299,000
Cannabis Canada [Member] | Decline of 1% in Terminal Growth Rate [Member]
Goodwill [Line Items]
Decrease in impairment to goodwill		$ 18,229,000
Additional decrease in terminal growth rate		1%
Increase in terminal growth rate		0.70%
Cannabis Canada [Member] | Decline of 5.0% in Future Cash Flow Rate [Member]
Goodwill [Line Items]
Increase in impairment to goodwill		$ 15,126,000
Additional decrease in future cash flow rate		5%
Decrease future cash flow rate		5.50%
Cannabis Canada [Member] | Decrease to Incremental Royalty Rate By 0.50% [Member]
Goodwill [Line Items]
Intangible assets		$ 3,469,000
Incremental royalty rate		3.50%
Decrease to incremental royalty rate		0.50%
Cannabis Canada [Member] | Increase of 2 to Discount Rate [Member]
Goodwill [Line Items]
Increase in post-tax discount rate		2%
Cannabis Canada [Member] | Decrease in Future Revenue Rate By 20% [Member]
Goodwill [Line Items]
Decrease to future revenues rate		20%
Cannabis Canada [Member] | Additional Increase of 1% to Discount Rate [Member]
Goodwill [Line Items]
Intangible assets		$ 308,000
Additional increase in post tax discount rate		1%
Cannabis U.S. [Member]
Goodwill [Line Items]
Intangible assets	$ 4,630,000	$ 0
Decrease in threshold percentage of revenue	0.25%
Threshold Percentage of Revenue	1.60%
Recoverable amount covering period		3 years
Recovered amount higher (lower) than carrying amount of goodwill	$ (25,169,000)	$ (13,500,000)
Amount of higher (lower) in carrying value of recovered amount of brand		380,000
Increase in impairment to goodwill	7,000,000
Recovered amount higher (lower) than carrying amount of brand	$ 9,250,000	$ 4,620,000
Cannabis U.S. [Member] | Increase of 1% to Discount Rate [Member]
Goodwill [Line Items]
Post-tax discount rate	11%	10%
Increase in post-tax discount rate	1%	1%
Increase in impairment to goodwill	$ 530,000	$ 4,100,000
Cannabis U.S. [Member] | Decline of 1% in Terminal Growth Rate [Member]
Goodwill [Line Items]
Increase in impairment to goodwill		$ 2,900,000
Terminal growth rate		4.10%
Increase in terminal growth rate		1%
Cannabis U.S. [Member] | Decrease to Incremental Royalty Rate By 0.50% [Member]
Goodwill [Line Items]
Intangible assets	$ 1,490,000	$ 3,320,000
Incremental royalty rate	4%	0.05%
Decrease to incremental royalty rate	0.50%	0.50%
Cannabis U.S. [Member] | Decrease in Future Revenue Rate by 10% [Member]
Goodwill [Line Items]
Intangible assets	$ 470,000
Decrease to future revenues rate	10%
Cannabis U.S. [Member] | Decline of 10% in Future Cash Flow Rate [Member]
Goodwill [Line Items]
Increase in impairment to goodwill		$ 2,500,000
Decrease future cash flow rate		10%
Cannabis U.S. [Member] | Decrease in Future Revenue Rate by 8 [Member]
Goodwill [Line Items]
Decrease to future revenues rate		8%
Cannabis U.S. [Member] | Additional Decrease in Future Revenue Rate by 5 [Member]
Goodwill [Line Items]
Decrease in impairment to goodwill		$ 220,000
Decrease to future revenues rate		5%
Cannabis U.S. [Member] | Increase of 0.5 to Discount Rate [Member]
Goodwill [Line Items]
Intangible assets		$ 420,000
Increase in post-tax discount rate		0.50%
Additional increase in post tax discount rate		0.50%

Goodwill and Intangibles Asse_3

Goodwill and Intangibles Assets - Schedule of Changes in Carrying Value of Goodwill by Reportable Segment (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Goodwill [Line Items]
Beginning Balance	$ 117,533
Purchase price adjustment	3,755
Reclass to intangible assets	(14,170)
Foreign currency translation adjustment	(2,224)
Impairments	(38,669)
Ending Balance	66,225
Cannabis Business [Member] | Canada [Member]
Goodwill [Line Items]
Beginning Balance	57,525
Purchase price adjustment	3,755
Reclass to intangible assets	(14,170)
Foreign currency translation adjustment	(2,224)
Ending Balance	44,886
Cannabis Business [Member] | United States [Member]
Goodwill [Line Items]
Beginning Balance	60,008
Impairments	(38,669)
Ending Balance	$ 21,339

Goodwill and Intangibles Asse_4

Goodwill and Intangibles Assets - Schedule of Acquired Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Finite Lived Intangible Assets [Line Items]
Less: Accumulated amortization	$ (4,013)	$ (1,550)
Less: Impairments	(4,630)
Intangibles, net	37,157	26,394
Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	17,691	12,835
Brand and Trademarks [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	12,719	12,951
Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	13,291
Computer Software [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	1,955	2,014
Other [Member]
Finite Lived Intangible Assets [Line Items]
Intangibles, gross	$ 144	$ 144

Goodwill and Intangibles Asse_5

Goodwill and Intangibles Assets - Schedule of Expected Future Amortization Expense for Definite-Lived Intangible Assets (Detail) $ in Thousands	Dec. 31, 2022 USD ($)
Fiscal period
2023	$ 3,320
2024	3,186
2025	3,100
2026	3,012
2027	3,012
Thereafter	13,294
Intangibles, net	$ 28,924

Line of Credit and Long-term _3

Line of Credit and Long-term Debt - Schedule of Debt (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Term Loan	$ 53,467	$ 61,836
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Term Loan	24,755	26,723
Term Loan (VFCE) [Member]
Debt Instrument [Line Items]
Term Loan		491
Term Loan One [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	9,664	11,870
Term Loan Two [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	14,867	17,806
B D C Facility [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Term Loan	$ 4,181	$ 4,946

Line of Credit and Long-term _4

Line of Credit and Long-term Debt - Schedule of Debt (Parenthetical) (Detail) - 12 months ended Dec. 31, 2022 $ in Millions, $ in Millions	USD ($)	CAD ($)
Term Loan (FCC Loan) [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment	$ 164
Debt instrument, interest rate during period	7.71%	7.71%
Debt instrument maturity date	Apr. 01, 2025	Apr. 01, 2025
Term Loan (VFCE) [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 3
Debt instrument, interest rate during period	4.98%	4.98%
Debt instrument maturity date	Jun. 30, 2023	Jun. 30, 2023
Term Loan One [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 19
Debt instrument, interest rate during period	8.70%	8.70%
Debt instrument maturity date	Feb. 29, 2024	Feb. 29, 2024
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
B D C Loan | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate during period	3.75%	3.75%
Debt instrument maturity date	Dec. 31, 2031	Dec. 31, 2031
Term Loan Two [Member] | Pure Sunfarms [Member]
Debt Instrument [Line Items]
Debt instrument, periodic principal payment		$ 25
Debt instrument, interest rate during period	8.70%	8.70%
Debt instrument maturity date	Feb. 29, 2024	Feb. 29, 2024
Debt Instrument Quarterly Payments Interest Rate	2.50%	2.50%
Debt instrument maturity date	Jun. 30, 2021	Jun. 30, 2021

Line of Credit and Long-term _5

Line of Credit and Long-term Debt - Additional Information (Detail) $ in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2022 CAD ($)	Dec. 31, 2021 CAD ($)
Disclosure Of Borrowings [Line Items]
Line of credit	$ 7,529	$ 7,760
Weighted average interest rate	9.12%	5.15%	9.12%	5.15%
Accounts Payable and Accrued Liabilities [Member]
Disclosure Of Borrowings [Line Items]
Accrued interest payable	$ 398	$ 304
Non-Revolving Variable Rate Term Loan 2021 [Member] | FCC Loan [Member]
Disclosure Of Borrowings [Line Items]
Securities pledged as collateral	113,159	233,187
Pure Sunfarms [Member]
Disclosure Of Borrowings [Line Items]
Inventory writedown excluded from loan	11,000
Revolving Operating Loan [Member]
Disclosure Of Borrowings [Line Items]
Amounts drawn on facility	4,000	4,000
Securities pledged as collateral	26,666	34,741
Revolving Operating Loan [Member] | Pure Sunfarms [Member]
Disclosure Of Borrowings [Line Items]
Total outstanding amount	$ 3,529	$ 7,760
Letter of Credit [Member] | Pure Sunfarms [Member]
Disclosure Of Borrowings [Line Items]
Line of credit			$ 4,145	$ 4,145

Line of Credit and Long-term _6

Line of Credit and Long-term Debt - Summary of Aggregate Annual Maturities of Long-Term Debt (Detail) $ in Thousands	Dec. 31, 2022 USD ($)
Debt Disclosure [Abstract]
2023	$ 8,309
2024	25,035
2025	23,190
2026	718
2027	671
Thereafter	2,213
Long-term debt	$ 60,136

Accrued Liabilities - Schedule

Accrued Liabilities - Schedule of accrued liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Received not invoiced	$ 6,252	$ 3,470
Accrued payroll	2,766	3,552
Accrued grower partner payables	824	2,248
Other	3,222	4,898
Accrued liabilities	$ 13,064	$ 14,168

Leases - Summary Of Lease Relat

Leases - Summary Of Lease Related Expenses (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease expense	[1]	$ 4,434	$ 2,926
Amortization of right-of-use assets			25
Total finance lease expense			$ 25
[1] Includes short-term lease costs of $ 999 and $ 680 for the year ended December 31, 2022 and 2021 .

Leases - Summary Of Lease Rel_2

Leases - Summary Of Lease Related Expenses (Parenthetical) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Short-term lease costs	$ 999	$ 680

Leases - Schedule Includes Othe

Leases - Schedule Includes Other Information About Leases (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating cash flows from operating leases	$ 604	$ 1,351
Operating cash flows from finance leases			$ 4
Financing cash flows from finance leases	$ 0	$ 17	$ 63
Weighted average remaining lease term:
Operating leases	5 years 6 months
Weighted average discount rate:
Operating leases	7.47%

Leases - Summary of maturities

Leases - Summary of maturities of lease matirities (Detail) - Operating Leases [Member] $ in Thousands	Dec. 31, 2022 USD ($)
2023	$ 2,616
2024	2,126
2025	1,911
2026	1,958
2027	1,350
Thereafter	2,168
Undiscounted lease cash flow commitments	12,129
Reconciling impact from discounting	(2,374)
Lease liabilities on consolidated statement of financial position as of December 31, 2022	$ 9,755

Financial Instruments - Additio

Financial Instruments - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Financial Instruments Owned And Pledged As Collateral [Line Items]
Fair value transfers between levels	$ 0	$ 0
Fair Value Inputs Level 3 [Member]
Financial Instruments Owned And Pledged As Collateral [Line Items]
Financial instruments net	$ 0	$ 0

Related Party Transactions an_2

Related Party Transactions and Balances - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Grid Loan Agreement [Member]
Related Party Transaction [Line Items]
Loans receivable, related parties	$ 0	$ 3,256
Employees
Related Party Transaction [Line Items]
Salary and benefits to employee	$ 115	$ 114	$ 118

Income Taxes - Summary of Incom

Income Taxes - Summary of Income Tax Provision (Recovery) (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax [Line Items]
Current	$ (5,150)	$ (660)	$ 3,672
Deferred	9,831	(2,866)	(6,462)
Provision For (Recovery Of) Income Taxes	4,681	(3,526)	(2,790)
US State [Member]
Income Tax [Line Items]
Current	72	135	260
Deferred	(2,085)	(176)	(434)
Provision For (Recovery Of) Income Taxes	(2,013)	(41)	(174)
Canadian [Member]
Income Tax [Line Items]
Current	(5,222)	(795)	3,412
Deferred	(2,734)	588	(1,149)
Provision For (Recovery Of) Income Taxes	(7,956)	(207)	2,263
US Federal [Member]
Income Tax [Line Items]
Deferred	14,650	(3,278)	(4,879)
Provision For (Recovery Of) Income Taxes	$ 14,650	$ (3,278)	$ (4,879)

Income Taxes - Summary of Effec

Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax [Line Items]
(Loss) income before income taxes	$ (96,734)	$ (12,651)	$ 8,818
Tax (recovery) calculated at US domestic tax rates	(20,339)	(2,592)	1,869
State tax adjustments	(1,799)	(230)	(310)
Non-deductible items	928	1,516	(6,531)
True up of prior year income tax estimates		(648)	(181)
Share of income from joint venture			(228)
Deferred adjustment	(3,324)	(2,429)	343
Tax rate differences on deferred items	308	397	49
Foreign rate differentials	88	86	1,643
Change in tax rates	5	5	37
Change in valuation allowance	28,684	57	3
Other	130	312	516
Provision For (Recovery Of) Income Taxes	$ 4,681	$ (3,526)	$ (2,790)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax [Line Items]
Federal statutory tax rate of Canada	27%	27%	27%
Federal statutory tax rate of United States	21%	21%	21%
Effective tax rate	4.80%	27.90%	(31.40%)
Valuation allowance	$ 30,419	$ 1,708
Net operating loss carry forwards	$ 106,428	74,607
Operating loss carry forwards, expiration year	2031
Uncertain tax benefits	$ 0	0
Income Tax Penalties and Interest	0	0
State and Local Jurisdiction [Member]
Income Tax [Line Items]
Net operating loss carry forwards	$ 42,768	28,189
Operating loss carry forwards, expiration year	2022
Foreign Tax Authority [Member]
Income Tax [Line Items]
Net operating loss carry forwards	$ 43,829	26,916
Foreign Tax Provincial Authority [Member]
Income Tax [Line Items]
Net operating loss carry forwards	$ 15,974	$ 13,409

Income Taxes - Summary of Defer

Income Taxes - Summary of Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Other assets	$ 5,536	$ 5,140
Long-term debt	943	832
Tax losses: Non-capital and farm losses	33,579	22,860
Provisions: Debt and unit issuance costs	1,683	2,194
Tax losses: Valuation allowance	(30,419)	(1,708)
Total deferred tax assets	11,322	29,318
Deferred tax liabilities:
Joint venture shares	(2,406)	(2,662)
Cash adjustment	(12,861)	(11,514)
Property, plant and equipment	(11,610)	(17,033)
Total deferred tax liabilities	(26,877)	(31,209)
Net tax assets	$ (15,555)	$ (1,891)

Segment and Geographic Inform_3

Segment and Geographic Information - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2022 Customer Segment	Dec. 31, 2021 Customer	Dec. 31, 2020 Customer
Segment Reporting Information [Line Items]
Number of operating segments | Segment	4
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Major Significant Customers [Member] | United States [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	51%	48%	79%
Number of major customers	1	2	2
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Major Significant Customers [Member] | United States [Member] | Minimum [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	10%	10%	10%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Major Customer One [Member] | United States [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	14.60%	20.10%	12.70%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Major Customer Two [Member] | United States [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage		10.60%	12.50%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Major Significant Customers [Member]
Segment Reporting Information [Line Items]
Number of major customers	1	1	2
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Major Significant Customers [Member] | Minimum [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	10%	10%	10%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Major Customer One [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage	19.10%	29%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Major Customer Two [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage			26.30%

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of Net Sales by the Countries and Property, Plant and Equipment, Net of Accumulated Depreciation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues [Abstract]
Revenues	$ 293,572	$ 268,020	$ 170,086
Interest expense [Abstract]
Interest expense	3,244	2,835	2,056
Interest income [Abstract]
Interest income	207	126	625
Depreciation and amortization [Abstract]
Depreciation and amortization	13,054	12,709	6,825
Gross margin [Abstract]
Gross margin	27,497	45,179	10,960
ASSETS
Assets	465,285	566,911
Property, plant and equipment, net [Abstract]
Property, plant and equipment, net	207,701	215,704
Produce Business [Member]
Revenues [Abstract]
Revenues	160,252	159,778	156,891
Interest expense [Abstract]
Interest expense	1,472	561	1,759
Depreciation and amortization [Abstract]
Depreciation and amortization	5,044	5,238	5,356
Gross margin [Abstract]
Gross margin	(17,382)	1,474	9,621
Cannabis Canada Business [Member]
Revenues [Abstract]
Revenues	109,882	96,434	12,778
Interest expense [Abstract]
Interest expense	1,768	2,236	243
Interest income [Abstract]
Interest income	11	9	2
Depreciation and amortization [Abstract]
Depreciation and amortization	7,445	5,875	822
Gross margin [Abstract]
Gross margin	29,388	37,209	2,193
Cannabis United States Business [Member]
Revenues [Abstract]
Revenues	23,302	11,345
Interest expense [Abstract]
Interest expense		1
Depreciation and amortization [Abstract]
Depreciation and amortization	565	299
Gross margin [Abstract]
Gross margin	15,659	7,947
Energy Business [Member]
Revenues [Abstract]
Revenues	136	463	417
Interest expense [Abstract]
Interest expense	4	37	54
Depreciation and amortization [Abstract]
Depreciation and amortization		1,297	647
Gross margin [Abstract]
Gross margin	(168)	(1,451)	(854)
Corporate [Member]
Interest income [Abstract]
Interest income	196	117	$ 623
United States [Member]
ASSETS
Assets	113,497	116,654
Property, plant and equipment, net [Abstract]
Property, plant and equipment, net	37,780	39,583
Canada [Member]
ASSETS
Assets	346,126	450,257
Property, plant and equipment, net [Abstract]
Property, plant and equipment, net	169,921	$ 176,121
Netherlands [Member]
ASSETS
Assets	$ 5,662

(Loss) Income Per Share - Summa

(Loss) Income Per Share - Summary of Basic and Diluted Net Income (Loss) per Ordinary Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Numerator:
Net (loss) income including non-controlling interests		$ (101,415)	$ (9,125)	$ 11,608
Less: net loss attributable to non-controlling interests, net of tax		269	46
Net (loss) income attributable to Village Farms International, Inc.		$ (101,146)	$ (9,079)	$ 11,608
Denominator:
Weighted average number of common shares – basic		89,127	82,161	58,526
Effect of dilutive securities – share-based employee options and awards				2,964
Weighted average number of common shares – diluted		89,127	82,161	61,490
Anti-dilutive options and awards	[1]	4,089	3,822	500
Net (loss) income per ordinary share:
Basic		$ (1.13)	$ (0.11)	$ 0.20
Diluted		$ (1.13)	$ (0.11)	$ 0.19
[1] Options to purchase shares of common stock and unvested RSUs are not included in the calculation of net (loss) income per share because the effect would have been anti-dilutive.

Shareholders' Equity and Shar_3

Shareholders' Equity and Share Based Compensation - Additional Information (Detail) - USD ($)		12 Months Ended
	Sep. 10, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Aug. 09, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Net proceeds from issuance of common stock / Shares issued in pubic offering, net of issuance costs (in shares)	9,396,226
Issued and sold of common shares		91,788,929	88,233,929
Description of units sold	Each unit that was sold consisted of one common share of the Company and one-half (0.5) of a warrant to purchase a common share of the Company
Class of warrant or right, exercise price of warrants or rights	$ 5.80
Warrants exercisable beginning date	Mar. 10, 2021
Warrants exercisable expiration date	Sep. 10, 2025
Number of warrants exercised		3,188,680
Option granted contractual term		10 years
Stock options vesting period		3 years	3 years
Weighted average grant date fair value		$ 3.31	$ 6	$ 4.65
Aggregate Intrinsic value exercised		$ 772,000	$ 2,273,000	$ 2,732,000
Unrecognized share based compensation expense		$ 5,692,000
Share based compensation cost expected period for recognition		3 years
Share based compensation expense		$ 3,987,000	$ 7,533,000	$ 6,142,000
Sales Agreement [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Issued and sold of common shares		3,175,000
Proceeds from issuance of common stock after deducting commissions and offering expenses		$ 6,692,000
Sales Agreement [Member] | Maximum [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Common shares aggregate offering price					$ 50,000,000
Stock Compensation Plan [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Maximum percentage of outstanding shares		10%
Number of shares available for issuance		5,069

Shareholders' Equity and Shar_4

Shareholders' Equity and Share Based Compensation - Summary of Fair Value Assigned To The Option Issues (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility			71.10%
Expected volatility, minimum	84%	68.30%
Expected volatility, maximum	89.90%	75.70%
Risk-free interest rate			0.52%
Risk-free interest rate, minimum	1.41%	1.07%
Risk-free interest rate, maximum	3.28%	1.54%
Expected life	6 years 6 months		7 years 1 month 6 days
Fair value			$ 4.65
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life		4 years 6 months
Fair value	$ 0.93	$ 4.29
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life		6 years 10 months 24 days
Fair value	$ 4.33	$ 7.31

Shareholders' Equity and Shar_5

Shareholders' Equity and Share Based Compensation - Summary of Stock Option (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted Average Remaining Contractual Term (years), Beginning balance	10 years
Aggregate Intrinsic Value, Exercised	$ 772	$ 2,273	$ 2,732
Stock Option [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Options, Beginning balance	3,622,558	3,067,322	2,452,666
Number of Options, Granted	725,360	792,236	1,081,488
Number of Options, Exercised	(180,000)	(177,000)	(425,166)
Number of Options, Forfeited/expired			(41,666)
Number of Options, Forfeited	(78,500)	(60,000)
Number of Options, Ending balance	4,089,418	3,622,558	3,067,322	2,452,666
Number of Options, Exercisable	2,549,401	2,042,663	1,618,168
Weighted Average Exercise Price, Beginning balance	$ 6.20	$ 5.42	$ 3.93
Weighted Average Exercise Price, Granted	2.74	8.47	6.54
Weighted Average Exercise Price, Exercised	1.30	1.07	1.01
Weighted Average Exercise Price, Forfeited/expired			5.17
Weighted Average Exercise Price, Forfeited	8.45	10.70
Weighted Average Exercise Price, Ending balance	5.76	6.20	5.42	$ 3.93
Weighted Average Exercise Price, Exercisable	$ 5.88	$ 4.80	$ 3.07
Weighted Average Remaining Contractual Term (years), Beginning balance	5 years 5 months 15 days	5 years 1 month 20 days	4 years 6 months 29 days	5 years 7 months 6 days
Weighted Average Remaining Contractual Term (years), Granted	9 years 8 months 12 days	9 years 9 months 10 days	9 years 9 months
Weighted Average Remaining Contractual Term (years), Exercised	6 months 3 days	1 year 1 month 20 days	1 year 7 months 13 days
Weighted Average Remaining Contractual Term (years), Exercisable	6 years 9 months 7 days	7 years 10 months 20 days	6 years 9 months 25 days
Aggregate Intrinsic Value, Beginning balance	$ 6,530	$ 15,735	$ 8,784
Aggregate Intrinsic Value, Granted	16	57	254
Aggregate Intrinsic Value, Exercised	772	1,813	2,039
Aggregate Intrinsic Value, Ending balance	152	6,530	15,735	$ 8,784
Aggregate Intrinsic Value, Exercisable	$ 133	$ 6,001	$ 11,865

Shareholders' Equity and Shar_6

Shareholders' Equity and Share Based Compensation - Summary of Non-vested Stock Option (Detail) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Share-Based Payment Arrangement [Abstract]
Number of Options, Beginning balance | shares	1,579,895
Number of Options, Granted | shares	725,360
Number of Options, Vested | shares	(696,238)
Number of Options, Forfeited | shares	(69,000)
Number of Options, Ending balance | shares	1,540,017
Weighted Average Grant Date Fair Value, Beginning balance | $ / shares	$ 5.28
Weighted Average Grant Date Fair Value, Granted | $ / shares	2.06
Weighted Average Grant Date Fair Value, Vested | $ / shares	5.35
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	5.75
Weighted Average Grant Date Fair Value, Ending balance | $ / shares	$ 3.72
Aggregate Intrinsic Value, Ending balance | $	$ 19

Shareholders' Equity and Shar_7

Shareholders' Equity and Share Based Compensation - Summary of Performance base restricted share unit activity (Detail) - Performance-Based Restricted Share Unit [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Number of Performance-based Restricted Share Units, Beginning balance	230,000	869,000	739,000
Number of Performance-based Restricted Share Units, Granted		158,000	1,068,000
Number of Performance-based Restricted Share Units, Issued			(840,000)
Number of Performance-based Restricted Share Units, Exercised	(200,000)	(487,000)
Number of Performance-based Restricted Share Units, Forfeited		(310,000)
Number of Performance-based Restricted Share Units, Forfeited/expired			(98,000)
Number of Performance-based Restricted Share Units, Ending balance	30,000	230,000	869,000
Number of Performance-based Restricted Share Units, Exercisable	30,000	200,000	75,000
Weighted Average Grant Date Fair Value, Beginning balance	$ 6.83	$ 5.89	$ 6.08
Weighted Average Grant Date Fair Value, Granted		7.72	4.75
Weighted Average Grant Date Fair Value, Issued			4.83
Weighted Average Grant Date Fair Value, Exercised	6.41	5.70
Weighted Average Grant Date Fair Value, Forfeited		6.66
Weighted Average Grant Date Fair Value, Forfeited/expired			7.16
Weighted Average Grant Date Fair Value, Ending balance	8.31	6.83	5.89
Weighted Average Grant Date Fair Value, Exercisable	$ 8.31	$ 6.49	$ 4.79

Shareholders' Equity and Shar_8

Shareholders' Equity and Share Based Compensation - Summary of Non-vested Performance-Based Restricted Share units (Detail) - Non-Vested Performance-Based Restricted Share Units [Member]	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Performance-based Restricted Share Units, Beginning balance | shares	30,000
Number of Performance-based Restricted Share Units, Vested | shares	(30,000)
Weighted Average Grant Date Fair Value, Beginning balance | $ / shares	$ 8.24
Weighted Average Grant Date Fair Value, Vested | $ / shares	$ 8.31

Changes in Non Cash Working Cap

Changes in Non Cash Working Capital Items - Summary of Changes in Non Cash Working Capital Items (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]
Trade receivables	$ 3,310	$ (9,914)	$ (3,196)
Inventories	(14,583)	(16,761)	2,997
Note receivable			765
Due from joint ventures		4	4,363
Other receivables	(4)	(399)	199
Prepaid expenses and deposits	3,815	(3,201)	(1,245)
Trade payables	6,697	6,327	(1,665)
Accrued liabilities	7,805	(10,389)	6,565
Other assets, net of other liabilities	(9,286)	(12,816)	4,289
Total	$ (2,246)	$ (47,149)	$ 13,072

Subsequent Event - Additional I

Subsequent Event - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions	Jan. 20, 2023	Sep. 10, 2020
Subsequent Event [Line Items]
Shares issued in pubic offering, net of issuance costs (in shares)		9,396,226
Exercise price of warrants		$ 5.80
Warrants exercisable beginning date		Mar. 10, 2021
Warrants exercisable expiration date		Sep. 10, 2025
Subsequent Event [Member]
Subsequent Event [Line Items]
Shares issued in pubic offering, net of issuance costs (in shares)	18,350,000
Purchase price	$ 1.35
Exercise price of warrants	$ 1.65
Proceeds from issuance of common stock before placement agent fees and offering expense	$ 25
Warrants exercisable beginning date	Jul. 30, 2023
Warrants exercisable expiration date	Jul. 30, 2028
Subsequent Event [Member] | Maximum [Member]
Subsequent Event [Line Items]
Warrants to purchase shares	18,350,000